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The Twin Arginine Translocase is a protein transport system in the inner membrane of both 
Gram-negative (E. coli) and Gram-positive (B. subtilis) bacteria. The translocase is unique 
as it exports fully folded substrates to the periplasm, moreover, it preferentially exports 
correctly folded proteins. Less information is known about the minimal Gram-positive 
translocases, TatAdCd and TatAyAy, but their ÔproofreadingÕ abilities and structure, 
respectively, are investigated alongside the usefulness of Tat in the biopharmaceutical 
industry.  
 
Initial studies (chapter 3) addressed which pharmaceutically recombinant proteins TatAdCd 
could export with a Tat specific signal peptide, TorA, to the periplasm. Surprisingly, the 
translocase only exported two scFvÕs, but by testing export of mutant scFvÕs I was able to 
determine, for the first time, the level of proofreading selectively by a Gram-positive Tat 
system.   
 
Given this knowledge, 8 scFv constructs in varying orientations from MedImmune were 
tested exploiting TatAdCd, Tat express and CyDisCo (chapter 4). I endeavored to optimize 
conditions for their expression and export through means of alternative mediaÕs and the 
fermentation process.  
 
Finally, given that Gram-positive Tat has unusual specificities and a minimal translocase, I 
used novel approaches to purify and characterise TatAyCy with SMA and CryoEM 
techniques (Chapter 5). The detailed insight provided in this study could help towards 
understanding the elusive translocation mechanism of Tat.  
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In order to function correctly and efficiently, every cell needs to be highly organised, 
tightly regulated and compartmentalised. Although prokaryotic cells are simpler than 
eukaryotic cells, bacteria too require specialised machinery to grow and thereafter thrive in 
niche environments.  
Proteins are essential macromolecules synthesised by ribosomes in the cytoplasm that often 
require localisation before they can carry out their particular purpose. Their proper 
formation, targeting and function are imperative to the survival of the cell. To name but a 
few functions, proteins replicate DNA, catalyse reactions, allow cellular locomotion and 
transport substrates from one location to the next. 
Prokaryotic bacteria can be broadly classified into two groups, Gram-positive and Gram-
negative. This is based on their ability to retain Gram-stain, which varies due to distinctive 
compartmentalisation differences. Gram-positive bacteria have a single cell membrane 
enclosed with a thick peptidoglycan wall whereas Gram-negative bacteria have a more 
complicated double cell membrane with a thin peptidoglycan wall. Hence, protein transport 
and destination can vary between the two classifications, see Figure 1. 
20-30% of proteins synthesised in the cytoplasm of bacteria are destined for extra-cytosolic
locations (Holland 2004), they therefore have to pass a cell membrane composed of a 
tightly sealed lipid bilayer intent on keeping the cell structurally sound and impenetrable. 
Specialised transport systems exist within the cell and the cell membrane to cross this 






A schematic representation of a Gram-positive cell (left) compared to a Gram-negative cell 
(right). Both cell types have a cytoplasm contained by the plasma membrane, encompassed 
by periplasm and the peptidoglycan cell wall. A Gram-positive cell has a thicker 
peptidoglycan wall compared to a Gram-negative cell. A Gram-negative cell has an 
additional cellular compartment, the outer membrane, which gives rise to an addition 
periplasmic space. 
  




















Figure 1. The differences between Gram-positive and Gram-negative cells 
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1.1.1 Protein translocation in bacteria 
A variety of protein transport mechanisms ensure proteins are translocated across or into 
the phospholipid bilayer without compromising its structural integrity or function. Each 
mechanism made up of essential proteins is as specialised as the protein substrate intended 
to use each system. However common features tie the pathways together, which guarantee 
cell regulation and safety, including: A gated pore (which stops unnecessary substance 
leakage), an energy requirement (to push the substrate through the membrane) and the use 
of signal peptides (that direct the protein to the correct translocase and intimately, the 
correct location).  
Two major transport systems exist for protein translocation and membrane insertion, The 
General Secretory (Sec) Pathway and the Twin Arginine Translocase (Tat) Pathway. Most 
proteins use the more abundant Sec pathway that is shared throughout all domains of life. 
In Eukarya the pathway functions in the ER whereas in Prokarya, it resides mainly in the 
plasma membrane to export unfolded proteins. The Tat pathway, the focus of this thesis, is 
much more exclusive, it has only around 30 native E. coli substrates (Palmer et al. 2011) 
and each protein is fully folded in the cytoplasm prior to Tat export. Figure 2, a schematic 
diagram, outlines the two alternative pathways by depicting their differences.   
To ensure proteins are directed to the appropriate pathway, signal peptides are encoded on 
the N-terminus of each protein. Their unique codes, or more exactly, amino acids guide the 
polypeptide through the cell to its correct location.  
4 
Proteins always originate from translating ribosomes and their N-terminal signal peptide 
(OmpA or TorA in this overview) will direct the nacent polypeptide chain to the correct 
translocase (Sec or Tat, respectively), aided by chaperones. The unfolded Sec protein is 
transferred to SecA where it is threaded through the SecYEG channel in the plasma 
membrane, powered by repeated cycles of ATP hydrolysis. In the oxidising periplasm, the 
unfolded protein matures into its tertiary fully folded protein. The Tat protein is fully folded 
within the cytoplasm (perhaps with a cofactor) and once directed to TatBC, TatA protomers 
recruit to translocate the protein across the plasma membrane. The energy required for this 




















































Figure 2. Two alternative protein translocation pathways, Sec and Tat. 
5 
1.1.2 Targeting via the signal peptide 
Substrates are targeted to the correct translocase by virtue of an N-terminal signal peptide 
with its mature protein in tow. The signal peptide and mature protein create a precursor 
protein. On the trans side of the membrane the precursor is cleaved by a signal peptidase to 
release just the mature protein (von Heijne 1990) (Lke et al. 2009). However resident 
plasma membrane proteins possess an N-terminal signal anchor sequence (usually in the 
first TM domain) which lacks a signal peptidase cleave site (Sakaguchi et al. 1992).  
Signal peptides differ in amino acid composition, but all bacterial signal peptides have a 
core tripartite structure: a positively charged N-terminal domain, a hydrophobic H-domain 
and a carboxylase C-terminal domain (Berks 1996). The aforementioned Ôcleavage siteÕ 
which is usually an Ala-x-Ala motif resides in the extreme of the C - domain. Figure 3 
outlines these distinct regions with both Tat and Sec signal peptide examples.  
The signal peptides are nevertheless distinguishable, a distinct difference is defined in the 
Tat pathway name, a highly conserved twin arginine motif is present in nearly all Tat signal 
peptides. A larger motif, S-R-R-x-F-L-K (where x is any polar amino acid) is present in 
>50% of Tat signal peptides and spans both the N- and H- domains (Sargent et al. 1998).
The importance of the other preserved amino acids in the larger motif depends upon the 
substrate and is varied in different bacteria (Berks et al. 2003). However, RR residues are 
invariant and essential for protein export, for example the substitution of RR > KK (a 
charge neutral change) blocks Tat export completely (Stanley et al. 2000). A single Arg to 
Lys mutation in most bacteria only slows down the rate of translocation (Buchanan et al. 
2002) but interestingly in chloroplasts RR > KR is tolerated but RR > RK stops transport 
6 
altogether (Chaddock et al. 1995)(Halbig et al. 1999). Indeed, the TtrB subunit of the 
tetrathionate reductase in Enterobacteriaceae is the only known native Tat substrate to have 
a KR motif (Hinsley et al. 2001) and experimentally the single substitution of Arg to Glu 
has been reported as tolerated too (DeLisa et al. 2002). Aside from the RR motif, other 
residues within the larger twin arginine motifs are important. The phenylalanine amino acid 
is important and present in 80% of Tat signal peptides, substitutions showed its high 
hydrophobicity is essential (Stanley et al. 2000). But what other differences are there 
between the Tat and Sec signal peptides? 
Tat signal peptides are at least 30 residues long, which is longer than Sec signal peptides, 
which are between 17 and 24 residues in length. The extra residues reside in the basic N-
domain and the hydrophobic H-domain (Kipping et al. 2003). Tat signal peptides are also 
overall less hydrophobic than Sec signal peptides, if the hydrophobicity of the signal 
peptide is increased, a Tat substrate can be directed to the Sec pathway (Cristbal et al. 
1999). Additionally, the C-domain of Tat signal peptides often contains basic residues 
(before the A-x-A motif) that are rarely found in Sec signal peptides. Several studies have 
suggested these basic residues are the ÔSec avoidance motifÕ whilst another study also 
including the AxA motif and the first five amino acids of the mature protein as ÔSec 
avoidingÕ (Bogsch et al. 1997)(Tullman-ercek et al. 2009).  
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Figure 3. Comparison of Tat (TorA) and Sec (OmpA) signal peptide. 
The structure of both signal peptides contains three regions a basic N-domain (blue), a 
hydrophobic H-domain (red) and a polar C-domain (green). A peptidase cleavage site 
(AxA) follows prior t the mature protein (pink). Below in corresponding colours are the 
amino acid sequences of TorA and OmpA signal peptides. Tat signal peptides (above) have 
a consensus motif containing the twin arginines, Sec signal peptides do not contain this. 
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1.2 The General Secretory Pathway (Sec) 
The Sec translocase is a ubiquitous membrane protein complex that serves to transport 
unfolded protein across or into the plasma membrane. The SecYE core channel is 
conserved across all Kingdoms of life, highlighting its importance, but this chapter will 
focus mainly on the bacterial Sec system. Indeed, E. coli used the Sec pathway for around 
96% of its exportome (Orfanoudaki & Economou 2014). 
Around 30 years ago genetic screens identified the main components of the E. coli Sec 
translocase and in the Ô90s the translocation pathway was reconstituted in vitro, which lead 
to the discovery of the intricate reactions creating the translocation event (Wickner & 
Leonard 1996). Several other Sec components were identified too, such as dedicated 
chaperones, SecB and SRP (Valent et al. 1998) alongside the motor which drives 
translocation, SecA ATPase (Lill et al. 1989). To understand the details of Sec function, its 
known structure must be revealed first. 
1.2.1 Sec membrane components 
The bacterial Sec translocon consists of three main components: SecY, SecE and SecG. 
SecY (48 kDa) is composed of 10 TM helices that can be divided into two sub-domains, 
TM 1-5 and TM 6-10. These form a clamp that are related to each other by a two-fold 
pseudo-symmetry axis and hence constitute the aqueous pore polypeptides are translocated 
through (Van Den Berg et al. 2004). The proposed translocation channel is located in the 
centre of the Y-subunit, which is blocked by an extension of TM2a, Ôthe plugÕ. Its distorted 
helix extends halfway to the centre of the membrane but cross-linking studies have shown 
that upon substrate binding, Ôthe plugÕ is displaced to open the channel (Van Den Berg et al. 
2004)(Tsukazaki et al. 2008). 6 isoleucine residues line the tightest part of the channel 
9 
which is an hour-glass shape and this hydrophobicity is predicted to form the seal around 
the transporting polypeptide to prevent any unwanted leakage and guide the substrate 
through (Park & Rapoport 2012). The interface between TM2 and TM7 form the Ôlateral 
gateÕ, contact with the pre-protein here induces the 2 halves to separate, allowing signal 
sequences into the lipid bilayer whilst TM5 and TM6 form Ôthe hingeÕ (Maillard et al. 
2005).  
Another component of the Sec translocon is SecE (14 kDa) (Schatz et al. 1989), without 
SecE, SecY is unstable and degraded, so SecE is essential for cell viability (Kihara et al. 
1995). E. coli SecE folds into 3 TM helices and although 2 are non essential (Murphy & 
Beckwith 1994) the other  TM docks across the interface of the two SecY-domains, 
clamping the ÔclamshellÕ closed. Specific protein-protein contact was identified at the C-
terminal end of SecE and TM2a (Harris & Silhavy 1999). 
SecG (12 kDa) in contrast to SecYE is not essential and does not exist outside the Bacterial 
Kingdom (Cao & Saier 2003). With 2 TM helices the subunit stabilises SecYE and 
enhances translocation rate by stimulating SecA activity (Matsumoto et al. 1998). Indeed 
SecG becomes more important when SecA is compromised by mutations or when SecA is 
critical (for example at low temperatures or low Transmembrane PMF) (Hanada et al. 
1996).  
Described above and in Figures 2 and 4 are the membrane components of the Sec pathway, 
other soluble proteins are yet to be explained. These include proteins such as the Signal 
Recognition Particle (SRP), SecA, SecB, and other components that aid the translocation 



































Figure 4. The Secretory pathway is either SecA or SRP dependent. 
A. Schematic of E.coli SecYEG. SecE (orange) has three transmembrane helices,
SecY (red) has ten transmembrane helices and SecG (green) has two transmembrane
helices. B. Nascent polypeptide chain emerges from the ribosome tunnel (pink), if it
has high hydrophobicity and is destined to be a membrane protein, a Signal
Recognition Particle named Ffh will bind. Once bound, the complex is directed to
SecYEG (red) and the GTPase activity of Ffh drives the disassociation of the
Ribosome Nascent Chain from the its own complex onto SecYEG. The RNC is
inserted int the SecY channel and when the ÔplugÕ (grey) is displaced, the protein can
enter its final destination, the inner membrane. Sometimes YidC is involved.
If the protein is less hydrophobic and destined for the periplasm, the cytosolic
chaperone Trigger Factor binds to the signal peptide of the protein. SecB also plays a
roll in preventing protein folding but SecA is the motor of this pathway. Its
association with SecYEG stimulates the hydrolysis of ATP, the ÔplugÕ (grey) moves
from SecY and protein translocated to the periplasm.
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1.2.2 The SRP pathway 
As the nascent polypeptide chain emerges from the ribosome tunnel, its encoded signal 
sequence dictates its rightful pathway. If thereÕs a high degree of hydrophobicity (von 
Heijne 1986) and helicity (Bruch et al. 1989), which are usually indicative of membrane 
protein, RNA is bound to the SRP. The SRP pathway is best described for Eukaryotes but it 
exists in Bacteria too.  
In E. coli the SRP protein subunit is named Ffh (Fifty-four homologue). The 48 kDa 
GTPase protein, Ffh and 4.5S RNA make up the ribonucleoprotein complex, in this co-
translocational process. Ffh has 3 domains, the C-terminal M domain binds substrate via its 
methionine rich region, which is predicted to provide a hydrophobic surface for signal 
sequence interaction (Zheng & Gierasch 1997) (Bernstein et al. 1989). Once bound, the 
Ribosome nascent-chain (RNC) complex is targeted to the inner membrane where it 
associates with its membrane anchored receptor FtsY that is located on the ribosome 
binding site of SecY (Kuhn et al. 2011).  
The GTPase activity of Ffh is unusual; it is still unclear what ultimately drives the 
completion of substrate handover. But it is understood that GTP hydrolysis drives the 
dissociation of the RNC-SRP complex so that the RNC fully docks onto the SecYEG 
machinery. The hydrolysis also drives the disassembly and recycling of the constituents, 
allowing them to continue protein targeting (Akopian et al. 2013).  
The signal anchor (SA) sequence of the RNC is inserted into the SecY channel and moves 
towards the lateral gate (Egea & Stroud 2010). When the ÔplugÕ is displaced in the SecY 
translocon, the protein enters its final destination, the inner membrane. 60% of all Sec-
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transported proteins are destined for the plasma membrane (Orfanoudaki & Economou 
2014). See Figure 4.  
 
1.2.3 The Sec pathway and YidC 
On the other hand, the nascent polypeptide chain may emerge from the ribosome tunnel 
less hydrophobic, in which case the cytosolic chaperone Trigger Factor (TF) binds to the 
signal peptide to prevent SRP binding (Beck et al. 2000). The protein is hence fully 
synthesised prior to locating its destination in this post-translocational pathway.  
Other chaperones too play a role, for example, SecB. Multiple copies of SecB bind to a pre-
protein that lacks tertiary structure to maintain its unfolded state and to prevent/delay 
aggregation (Kumamoto 1989)(Bechtluft et al. 2007). Moreover, SecB relays pre-proteins 
to either the smaller portion of cytosolic dimer SecA or the monomer SecA, associated with 
the phospholipid head groups and SecYEG (Lill et al. 1990). To note, when not bound to 
SecB, SecA only transiently interacts with SecYEG. However SecA-SecYEG interaction 
increases the affinity of SecA-SecB complex (Hartl et al. 1990), which is explained soon.  
 
SecA is an essential, large 102 kDa protein which acts as the Sec translocase motor. ItÕs 
Nucleotide Binding Domain (NBD) 1 and NBD2, the intra-molecular regulator of ATPase 
2, sandwich a single nucleotide (Tsirigotaki et al. 2017). NBD2 docks SecA onto SecY at 
which stage, the greater interactions between SecA and SecB leads to an exchange of ADP 
for ATP at NBD1, SecB is then released. Hydrolysis of ATP at NBD1 promotes NBD2 
ATP hydrolysis. The pre-protein stimulates ATP hydrolysis through the triggered SecA 
protein and the proteinsÕ mature domain becomes trapped in the SecA-SecYEG complex, 
SecA monomerises (Gouridis et al. 2009). Through unknown mechanisms, the signal 
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peptide relocated to the Ôlateral gateÕ and the ÔplugÕ from SecY is moved to translocate the 
protein through the channel approximately 30-40 amino acids at a time (Schiebel et al. 
1991). 
 
The translocation is achieved by either SecA acting as a piston to push the protein through 
by ATP binding and hydrolysis, like power strokes (Bauer et al. 2014) or SecA acting as an 
Ôallosteric channel regulator, SecA conformations control SecYEG through cycles of ATP 
hydrolysis. The latter would facilitate a Brownian-ratchet mechanism, the pre-protein 
diffuses across the membrane without energy requirement and SecA prevents chain 
backsliding via PMF (Allen et al. 2016).  
Once most of the mature protein is translocated, SecA loses contact with SecY and ATP 
stimulation is lost. Signal peptidases cleave the signal peptide and the mature protein is 
released to the trans side of the plasma membrane (Auclair et al. 2012). 
 
Some proteins require the aid of YidC, a 62 kDa homologue to both Oxa1p and Alb3 found 
in mitochondrial inner membranes and thylakoid membranes, respectively (Saaf et al. 
1998).  Their job is to insert proteins into the membrane, YidC is essential for the F0 
domain of the E. coli F1F0 ATPase and cytochrome o oxidase of the electron transport 
machinery. With 6 TM domains, YidC receives these SRP substrates and mediates their 
insertion to SecY. Indeed, it has been shown that YidC interacts directly with FtsY (Welte 
et al. 2012) and that it can occupy the SecYEG translocon (Sachelaru et al. 2013). 




1.3 The Twin Arginine Translocase (Tat) Pathway 
The Twin Arginine Translocase (Tat) pathway differs from the other protein pathways 
discussed so far because Tat transports fully folded proteins.  
 
In the early 1990Õs, the alternative translocase was discovered in the thylakoid membrane 
of chloroplasts, which worked in parallel to the Sec pathway (Mould & Robinson 1991). 
Initially named the ΔpH-dependent pathway in thylakoids (due to its unusual sole 
requirement of a proton gradient for translocation), (Klsgen et al. 1992), three membrane 
proteins were soon identified in thylakoids as essential for translocation of fully folded 
proteins (Clark & Theg 1997). Tha4 (Mori et al. 1999), Hcf106 (Settles et al. 1997) and 
cpTatC (Cline & Mori 2001). 
 
Not long after, homologues to the complex were found expressed in some bacteria, archaea 
and mitochondria (Yen et al. 2002). In E. coli, Tat substrates are exported across the plasma 
membrane into the periplasm via TatA, TatB and TatC (homologues to thylakoid proteins 
Tha, Hcf106 and cpTatC, respectively). (Bogsch et al. 1998)(Sargent et al. 1998)(Sargent et 
al. 1999). This system was named Mtt, Membrane Targeting and Translocation and the 
importance of the complex in E. coli was highlighted when several integral proteins were 
mislocalised in Mtt knockouts (Weiner et al. 1998). Finally however, the system was 
renamed the Twin Arginine Translocase (Tat) pathway as virtually every protein targeted to 
it has a twin arginine motif in its signal peptide. 
 
The function of the Tat pathway is to transport a subset of more complex proteins that 
require cofactor insertion or immediate oligomerisation (Berks 1996). Therefore, the 
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pathway is essential for many processes including energy metabolism, cell division, cell 
envelope biogenesis, quorum sensing, motility, symbiosis and pathogenesis (Palmer et al. 
2005)(Bernhardt & De Boer 2003)(Ize et al. 2003)(Ding & Christie 2003). Tat can even 
export more complex heterologous proteins than Sec. Tightly folded proteins such as 
dihydrofolate reducase (bound to methotrexate) and GFP with a Tat signal peptide are some 
early examples (Hynds et al. 1998)(Santini et al. 2001), now more bio-pharmaceutically 
relevant proteins have too been exported via Tat (Alanen et al. 2014). But another 
intriguing attribute of the pathway lies in its innate ability to detect unfolded or mutated 
proteins. Indeed, Tat can ÔproofreadÕ proteins and reject them for export if they have not 
been synthesised and folded correctly (Delisa et al. 2003)(Richter & Brser 2005a).  
 
This unique platform means recombinant proteins are produced with high quality; products 
are homogeneous and relatively pure from the periplasm. However after nearly three 
decades of studies, little is still known about TatÕs export mechanism, its proof reading 




1.3.1 Bacterial Tat genes 
The Tat system in E. coli is expressed from the tatABCD operon and while they are all 
constitutively expressed, TatA is expressed 50 times and 25 times more than TatC and 
TatB, respectively (Jack et al. 2001). This difference reflects the final component make-up 
of the Tat translocase in the plasma membrane. tatD, is expressed further downstream and 
whilst originally its function was unknown, more recently TatD is thought to aid 
proofreading proteins (Matos et al. 2008). Elsewhere in E. coliÕs genome, tatE is expressed, 
TatE is thought to be a late gene duplication of TatA (Baglieri et al. 2012). Although 
ΔtatABCDE strains are viable, as the Tat system is important for many essential cellular 
functions, pleiotropic cells defects including impaired septation, decreased motility and an 
increased sensitivity to detergent are apparent (Stanley et al. 2001). 
 
The Tat complex can minimally function with TatA-like and TatC-like proteins, although 
this varies greatly between organisms (Goosens et al. 2014b). Bacillus subtilis expresses 
two minimal pathways, tatAdCd and tatAyCy, from different operons (Jongbloed et al. 
2004). TatAdCd is expressed with its only known substrate, PhoD during phosphate starved 
conditions (Beck et al. 2009).  In contrast, TatAyCy is expressed constitutively with several 
substrates such as YwnN (EfeB), QcrA and YkuE (van der Ploeg et al. 
2011)(Monteferrante et al. 2012). A third TatA gene, tatAc is expressed elsewhere in the 
genome, it is thought TatAc could represent an intermediate step between TatA and TatB 
(Goosens et al. 2015).  
The organisation of both E. coli and B. subtilis tat genes are shown in Figure 5. 
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E. coli tatABC genes (above) are constitutively expressed from a single gene, these make 
up the essential translocase. tatD is expressed from the same operon, but further 
downstream, whereas tatE is expressed elsewhere in the genome.  B. subtilis tat genes 
(below) are expressed in separate operons alongside their respective substrates. tatAdCd is 













Figure 5. Organisation of bacterial Tat genes in E. coli and B. subtilis 
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1.3.2 Escherichia coli Tat components 
1.3.2.1 TatA 
TatA is the most abundant component of the Tat complex, most likely responsible for 
forming the translocase channel (Sargent et al. 2001). E. coli has a core TatA protein but it 
also has TatA-like proteins, TatB and TatE which arose due to gene duplication events, but 
following sequence divergence now have specialised functions, discussed later (Yen et al. 
2002).  
 
B. subtilis has three TatA proteins, TatAd, TatAy and TatAc (Goosens et al. 2014). TatA 
and TatA-like proteins can be interchanged and function both intra / inter- bacteria. For 
example, TatE can substitute TatA (Baglieri et al. 2012), TatAd can substitute TatA and 
TatB (Barnett et al. 2008) and TatAc can form active translocases with TatCd and TatCy 
(Monteferrante, Baglieri, et al. 2012) and functionally replace TatA and TatE (Beck et al. 
2013). This is interesting as the functional overlaps suggest a universal translocation 
mechanism independent of TatA protein size as E. coli TatA is 9.6 kDa (Porcelli et al. 
2002) and B. subtilis TatAd is 7 kDa (Barnett et al. 2008). 
Table 1 displays E. coli and B. subtilis Tat protein components sizes and their complex 
sizes. 
 
TatA and TatA-like proteins have similar structures, a short N-terminal domain which is 
exposed to the periplasm (Koch et al. 2012), followed by a single TM helix linked to an 
amphipathic helix (APH) which lies against the membrane (Hu et al. 2010) and the C-
domain which forms an unstructured and hydrophilic tail in the cytoplasm (Rodriguez et al. 
2013).  NMR experiments on B. subtilis TatAd have confirmed the L shape arrangement 
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and have indicated the TM helix (14-16 residues in length) is tilted by 17o, which has 
translocation implications (Mller et al. 2007). This arrangement was supported and 
enhanced with the knowledge that the following APH is aligned with a comparatively steep 
tilt angle against the membrane (Walther et al. 2010). Contrary to the previous predicted 
conformation, which implied the APH was flat against the membrane (Lange et al. 2007), 
the APH now too has a key role in transformation assembly.  
 
Surprisingly, not many substitutions in TatA block export, but there are a few instances. In 
E. coli a glycine residue in the Òhinge regionÓ connects the TM helix and the APH, indeed, 
the mutation G33A stops export, suggesting this a key residue alongside others (Barrett et 
al. 2003). The mutant F39A also inactivates the translocase, this residue anchors the APH 
to the membrane (Hicks et al. 2003). Lastly, using cysteine-scanning mutagenesis other 




TatE (7 kDa), is a much smaller TatA-like protein that shares 57% similarity with TatA 
(Sargent et al. 1998). Given it is smaller and is 100 times less abundant than TatA, it was 
thought TatE had no real function in the Tat translocon (Jack et al. 2001). More recently 
however, it was shown TatE could substitute TatA (Baglieri et al. 2012) and that TatE was 
a regular constituent of the Tat translocase (Eimer et al. 2015). The role of TatE is much 
more active than thought, TatE has been shown to interact with the Tat signal peptide and 
even partially prevent premature cleavage of TorA signal peptide (Eimer et al. 2018). In 
fact, TatE homologues have been found in many other bacteria species too, B. subtilis 
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TatAc has 45% amino acid sequence similarity to TatE, suggesting unique TatE-paralogs 
exist which may bridge the gap between the functions of TatA and TatB. 
 
1.3.2.3 TatB 
TatB is functionally different to TatA, its role is to bind the Tat signal peptide and 
subsequent mature protein. Despite only sharing 20% sequence identity to TatA and being 
nearly double TatAÕs size (18.5 kDa), TatB is predicted to have a very similar structure and 
topology (Hicks et al. 2003). However TatB does have a slightly longer APH (by 12 amino 
acids) (Zhang, et al. 2014) and a longer unstructured C-terminal (Lee et al. 2002). Only 
mutations in Òthe hingeÓ region and APH cause translocation defects (Barrett et al. 2003).  
Single N-terminal amino acid substitutions in TatA allow complementation to ΔtatB strains 
(Blaudeck et al. 2005)(Barrett et al. 2007) which perhaps validates the knowledge that TatB 
came from a TatA gene duplication event, but later specialised. The bifunctionality of TatA 





TatC is the largest (32 kDa) protein in Tat complex that aids substrate binding (Tarry et al. 
2009). TatC is also has the most conserved sequence across bacteria and plants, with most 
conservation in its cytoplasmic loops (Kneuper et al. 2012), this preservation highlights the 
central role TatC has in the translocation event. 
Its structure is very different to other Tat components as it has 6 TM helices with an N-in 
C-in topology (Behrendt et al. 2004). The crystallisation of TatC from Auifex aeolicus  
(which shares 40% sequence identity to E. coli Tat C) in 2013 gave new insights into the 
structural basis of each TM domain (Ramasamy et al. 2013). TM1 is perpendicular to the 
membrane whilst TM2 is at a tilted angle until a conserved proline residue creates a kink. 
TM3 is even more tilted and contacts TM2/4/6, reminiscent of SecE, suggesting a role in 
overall stabilization. TM4 is very similar to TM2, it has a proline kink and a conserved 
glycine (Gly170). TM5 is the shortest helix, it contacts TM4 and ends with a highly 
conserved proline turn. TM6 is also very short, it has a relatively shallow angle and 
contacts TM3/4/5. Overall, these structures result in a membrane protein that resembles the 
shape of a baseball glove or a cupped hand. How? Most helices are titled at angles between 
20o and 40 o to the membrane, TM2/3/5 are strongly kinked and TM5/6 are too short to 
span the whole membrane. TatC shows very restricted structural flexibility (usually seen in 
small molecule transporters), so itÕs unlikely it undergoes a big conformation change upon 
translocation (Rollauer et al. 2013).   
A notable surface feature of TatC is the conserved side chain, Glu165 in A. aeolicus or 
Glu170 in E. coli (Rollauer et al. 2013)(Buchanan et al. 2002). Its intriguing location in the 
interior of the bilayer perturbs membrane bilayer structure and indeed a recent study 
identified this residue as part of or close to the binding pocket for Tat signal peptides 
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(Blmmel et al. 2017). Other important residues are localised to the cytoplasmic N-region 





Figure 6. Schematic of E. coli TatABC components in the plasma membrane 
Three essential components form the Gram-negative Tat complex, TatA, TatB and TatC. 
TatA/E and TatB have similar topologies in that they have one TM domain with a short 
periplasmic N-terminal region, a tilted APH and an unstructured C-terminus on the 
cytoplasmic side of the plasma membrane. To note, TatB is larger than TatA with a longer 
C-terminal tail. TatC is significantly bigger as it containing 6 TMÕs with both C and N 
terminals residing in the cytoplasm. TM 5 and 6 do not fully span the membrane, which 
may contribute to its function. 
 
1.3.2.5 TatD 
TatD is the final constituent of the E. coli Tat system; itÕs different because itÕs a soluble 
cytoplasmic protein (28.9 kDa). Neither mutant or overproduction of TatD has effects on 
substrate export nor as purified TatD exhibits a magnesium-dependent DNase activity, itÕs 
difficult to see its role in the Tat translocase (Wexler et al. 2000).  
  
  





























1.3.3 Bacillus subtilis Tat components 
B. subtilis is the model organism for Gram-positive bacteria, itÕs both easy to genetically 
manipulate and industrially relevant (as it secretes proteins to medium), but little is known 
about its minimal Tat system. As mentioned in Section 1.3.1 Bacterial Tat genes, B. subtilis 
has only TatA and TatC subunits, like all Gram-positive bacteria (except Actinomycetes) 
(Schaerlaekens et al. 2001). B. subtilis TatA is bifunctional by acting as both E. coli TatA 
and TatB. The more homogeneous complexes TatAd-TatCd, TatAy-Cy and TatAc work in 
parallel with different substrate specificities (Jongbloed et al. 2004). 
 
1.3.3.1 TatAdCd 
TatAdCd exists as a complex of approximately 230 kDa, TatAd alone is 6.5kDa (but ~ 
 270 kDa in a complex) and TatCd alone is 25 kDa (Barnett et al. 2008). TatAd has the 
same essential structure and regions as E. coli TatA (Hu et al. 2010). However, when 
TatAdCd is expressed in E. coli, a TatAd mutant with substitutions in the C-terminal part of 
its TM dramatically reduces translocation, but the same E. coli TatA mutation only leads to 
a drop in translocation activity (Barnett et al. 2011). The same study showed mutagenesis 
of the extreme N-terminus (including the short periplasmic domain and the N-terminal half 
of the TM span) of TatAd blocked translocation in ΔtatB cells. Clearly then, these are 
important to the ability of TatAd to substitute for TatB in E. coli and hence, might be linked 
to its bi-functionality. Structural data has also changed the way TatA has been perceived. It 
was thought TatA formed the pore that proteins went through. However, EM images show 
TatAd complexes too small and too homogeneous for Tat substrates (Beck et al. 2009), 





TatCd both has an affinity for and stabilises TatAd, perhaps the residues responsible for 
interaction are in the loops flanking the fifth domain (Schreiber et al. 2006). TatCd is also 
very similar to E. coli TatC with 6 TM helices which are slightly tilted with respect to the 
bilayer normal (Nolandt et al. 2009). 
 
1.3.3.2 TatAyCy 
TatAyCy is 200 kDa, TatAy alone is 6 kDa, a TatAy complex is about 200 kDa and TatCy 
alone is 28 kDa (Goosens et al. 2014). 
TatAy (like TatAd) has a similar structure to E. coli TatA, for example the conserved hinge 
region of TatAy is as important in TatAd and E. coli TatA (Barnett et al. 2011). However, 
only in Gram-positive bacteria, a conserved residue (P2) exists in the N-terminal 
extracytoplasmic region. Indeed, the equivalent residue (P8A) in TatAd was shown to be 
particularly important for the bifunctionality of TatAd (Barnett et al. 2011). In TatAy, P2 
mutants either completely or partially stop protein export (Goosens et al. 2015). Moreover, 
a different study with the same P2A mutant showed via EM and advanced atomic force 
microscopy that when mutated large fibrils accumulated which are chains of numerous 
complexes (Patel et al. 2014). The combined data suggest the mutant is impaired in pore 
formation, not docking complex formation. 
 
TatCy is predicted to have 6 TM helices like other TatCÕs discussed, but the extreme C-
terminus of TatCy is extended by 5 amino acids compared to TatCd, these residues are 
important for YwbN export (Eijlander et al. 2009). Indeed, the N-terminus and the first 
cytoplasmic loop and the C-terminal tail of TatC, TatCd and TatCy are important for 
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translocation, but intriguingly, the importance of the conserved residues varies and the 
effects of amino acid substitutions differ depending on the substrate (Eijlander et al. 2009). 
1.3.3.3 TatAc 
TatAc is the third TatA like protein in B. subtilis, itÕs constitutively expressed and until 
recently thought to be redundant as ΔtatAc cells showed no phenotype. However, more 
recently the protein has been shown to be active. When expressed in E. coli, TatAc is able 
to make complexes with TatCd and TatAy to form TatAcCd and TatAcAy which can 
export endogenous Tat substrates such as AmiA, AmiC and TorA (Monteferrante et al. 





E. coli Size of gene 
product (kDa) 
 Size of complex 
(kDa) 
Reference 
TatA 11 50-500  (Oates et al. 2005) 
TatB 18  100  (Orriss et al. 2007)  
TatC 30 220 (Orriss et al. 2007)  
TatE 7  50-110  (Baglieri et al. 2012)  
TatABC  440-580 (Behrendt et al. 2007) 
B. subtilis Size of gene 
product (kDa) 
 Size of complex 
(kDa) 
Reference 
TatAd 7  200* (Barnett et al. 2008)  
TatCd 27  100 (Monteferrante et al. 2012)  
TatAy 6  200* (Barnett et al. 2009)  
TatCy 28 66 (Monteferrante et al. 2012)  
TatAc 6  100 (Monteferrante et al. 2012)  
TatAdCd  230 (Monteferrante et al. 2012)  
TatAyCy   200 (Monteferrante et al. 2012)  
Table 1. Tat components and complexes sizes of E. coli and B. subtilis. 
The predicted protein sizes of E. coli and B. subtilis Tat components according to gene 
sizes. Complex sizes were determined mostly by blue-native gel electrophoresis, except 




1.3.4 The Tat complex 
The Tat system transports folded proteins; its largest native substrates are heterodimeric 
formate dehydrogenases of nearly 150 kDa (Berks et al. 2000). However, Tat components 
themselves are relatively small so the translocase must coalesce with multiple copies of 
each individual subunit. Live fluorescence microscopy shows the TatABC system 
assembling on demand to newly synthesised Tat substrates, reorganising individual 
subunits in an uniform manner in the plasma membrane (Rose et al. 2013). Two complexes 
exist, the TatBC complex and the TatA complex. It is widely accepted that TatBC forms a 
receptor complex that binds Tat substrates initially at the membrane. Substrate binding 
triggers PMF-dependent TatA recruitment and oligomerisation to form an active 
translocase, suggesting TatA has a role in the translocation event (Berks et al. 2014). The in 
vitro cycle is slow, starting from substrate bound TatBC, the translocation event takes 1-3 
mins (Celedon & Cline 2012). Disassembly of TatA from TatBC requires substrate export 
(Alcock et al. 2013) and the mechanism of the translocation is discussed in the next 
chapter. 
 
1.3.4.1 The TatBC complex 
TatBC interacts in a 1:1 stoichiometry (Bolhuis et al. 2001) and several TatBC complexes 
bind the substrate(s) (Behrendt & Brser 2014). Low resolution EM structures of the 
TatBC complex revealed a hemispherical morphology, with an internal cavity which could 
accommodate the signal peptide (Tarry et al. 2009). 7 copies of TatBC are able to fit into 
the 11-17nm reconstruction, however when a Tat substrate was also expressed, only 2 
substrates bound at a single time (not 7). This at least supports that more than one substrate 
can bind at once (Ma & Cline 2010). Though the question still remains, how does the Tat 
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signal peptide and protein interact with the TatBC complex? 
Cross-linking studies show TatC is the primary interaction site of the signal peptide (Grard 
& Cline 2006)(Alami et al. 2003)(Kreutzenbeck et al. 2007). More specially, the N-region 
(containing the RR motif) of the signal peptide binds to residues in the TatC cis 1 domain 
and cis 2 loop (Zoufaly et al. 2012). The signal peptide is inserted deep into the TatC 
(Grard & Cline 2006) by perhaps adopting a hairpin loop confirmation (Ramasamy et al 
2013). In which case, the signal peptide could extend to expose its C-region signal 
peptidase site at the periplasmic side of the membrane (Frbel et al. 2012) (Blmmel et al. 
2015). However, this model does not account for TatBÕs role. 
 
Cross linking experiments have also shown the signal peptide H domain can interact with 
the TatB TM (Alami et al. 2003) and Tat precursors can bind to TatB at multiple sites early 
on (Maurer et al. 2010). Although high resolution structural information is lacking 
regarding TatB, NMR data can confirm its extended C-terminal is relatively flexible and 
able to facilitate substrate binding (Zhang et al. 2014). Thereafter, each TatC monomer has 
2 contact sites for TatB. One is located around the TM5 of TatC (Kneuper et al. 2012), 
notably TM5/6 of TatC are shorter and therefore able to accommodate the TM of TatB, 
cross-linking data supports this (Rollauer et al. 2012). Whilst the other binding site is 
positioned between TM4 and TM2 of TatC (Blmmel et al. 2015), both these locations are 
important for TatBC oligomeric structure, discussed shortly.  
Of interest, other than binding substrates and binding to TatC, TatB could also have a role 
in preventing premature signal peptide cleavage (Frbel et al. 2012). When TatB was 





The exact arrangement of the functioning TatBC structure is still unclear, but photo and 
disulphide cross-linking studies have provided some insight. As mentioned previously, 
TatB can cross-link to TM2/4 and TM5 of TatC (Blmmel et al. 2015), they interpreted this 
as each TatB TM bridges TM2/4 of one TatC and TM5 of another TatC, supported by other 
data, see Figure 7 (Maurer et al. 2010)(Lee et al. 2006). This is intriguing as it places the 
TM of TatB close to where TatA initiates translocase oligomer assembly, supporting the r 
ole of TatB as a regulatory surrogate of TatA, especially due to their high level of 





































































































































































A. A schematic diagram depicting the 1:1 stoichiometry of the TatBC complex. 7 copies of TatBC form a complex with two Tat substrates bound to TatC (blue) via deep signal peptide 
insertion. Each TatC has 6 TMHÕs (numbered) and is bridged by TatB (purple) via TM2/4 and TM5 of TatC. 
B. TatC has a polar cluster of amino acids at TM5/6 (yellow star), without a bound substrate this site is occupied by TatB. Substrate binding brings on a position switch; TatB vacates 
the site for TatA to bind. Thereafter, the nucleation of TatA (green) promoters starts to form the translocation unit. Figure based on Rollauer et al 2012.  
!




1.3.4.2 TatCÕs Ôpolar clusterÕ 
More recently, coevolution analysis predicted a location for TatA and TatB binding along 
TM5/6 of TatC, indicating a Ôpolar clusterÕ of amino acids on TatC likely form contact with 
a polar side chain of TatA or TatB. Both TatA and TatB can occupy the same TatC TM5/6 
site at different stages of transport (Alcock et al. 2016). Disulphide cross-linking has 
confirmed the Ôpolar clusterÕ interactions (Habersetzer et al. 2017).  The paper further 
demonstrates that upon substrate binding, TatA cross linking to the TM6 site is reduced, 
TatB cross linking at the polar site is reduced and TatA binding at the polar site is 
increased. This position switch is probably bought on by signal peptide binding deep into 
the complex; the polar cluster site is adjacent to the docking site of the signal peptide 
(Eimer et al. 2015) and this could cause the conformational rearrangements. Signal peptide 
binding also altered TatCÕs resting state arrangement of head-to-tail to tail-to-tail. This 
opens up the complex and allows TatA access to the vacated polar cluster site. Binding of a 
TatA molecule to this site places it adjacent to the concave face of TatC where the 
nucleation of TatA has been suggested (Rollauer et al. 2012). See figure 7. 
 
1.3.4.2 The TatA complex  
TatA is the subunit that facilitates the translocation event, either by forming a pore by 
which the substrate can go through (Gohlke et al. 2005) or by weakening the lipid bilayer 
(Brser & Sanders 2003).  
 
While TatA is not obligatory for TatBC formation or substrate docking (Orriss et al. 2007), 
trace amounts of TatA are observed in association with the TatBC complex which may the 
nucleation points for other TatA oligomers to join and form the translocase (Aldridge et al. 
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2014). TatA is expressed 20 times more than TatBC (Sargent et al. 2001) and if TatB is 
overexpressed compared to TatAC, Tat is inactivated (Sargent et al. 1999) perhaps because 
it is blocking the Ôpolar clusterÕ on TM5 of TatC. 
 
The exact concentration of TatA required to catalyse membrane export in thylakoids was 
calculated in the 100 nM range, but of more interest, TatAÕs kinetics suggests the Tat 
translocase operates as an allosteric enzyme complex (Hauer et al. 2013), this fits with the 
Ôpolar clusterÕ position switch theory (Habersetzer et al. 2017). However, the exact number 
of TatA subunits that oligomerise within the complex is more complicated. TatA 
complexes in E. coli demonstrate a high heterogeneity as TatA complexes vary in size from 
100 kDa to 500 kDa as identified by Blue Native PAGE (Oates et al. 2005). These 
complexes can be resolved at 34 kDa intervals, supporting an idea of modular formation of 
3 or 4 complexes at a time. But after substrate export, the transient complex disassembles, 
so itÕs difficult to capture the event. One study controlled oligomer size by detergent ratio 
and solution NMR indicated self oligomerisation is through TatAÕs TMH (Rodriguez et al. 
2013). Multi-experimental techniques supports this (White et al. 2010)(Zhang, Wang, et al. 




1.4 TatÕs mechanism of translocation 
Although the primary role of each Tat component is understood, the TatBC complex binds 
Tat substrate, which triggers TatA oligomerisation and mediates the translocation event, the 
mechanistic process is still not fully resolved.  The initial and well accepted model, the 
ÔTranslocation pore modelÕ theorises that TatA forms a channel/pore which proteins 
translocate through (Gohlke et al. 2005). However, more recent data has cast doubt on this 
idea (Baglieri et al. 2012) and an alternative model is now more supported, the ÔMembrane-
destabilisation modelÕ (Brser & Sanders 2003). The latter was a hypothesis with little 
evidence until very recently, Hou et al proved the TatA destabilises the membrane upon Tat 
substrate binding (Hou et al. 2018).  
 
1.4.1 Translocation pore model 
Low-resolution images of TatA revealed a pore like complex of varying diamaters (8.5 Ð 13 
nm) that would explain the significant heterogeneity seen on BN-PAGE gels and more 
importantly, accommodate TatÕs varying substrate sizes (Gohlke et al. 2005)(Sargent et al. 
2006). To prevent ion leakage, a lid-type feature was also identified on the inner side of the 
cytoplasmic membrane, as if the transporter were a trap door. Moreover, the flexibility 
implied by the conserved glycine hinge in TatA suggested that such a rearrangement was 
plausible (Gouffi et al. 2004). Perhaps, TatAÕs APH swings down (into a hairpin) to align 
with its TMS so the polar residues on the APH would constitute the inner lining of a pore 
and allow hydrophilic cargo passage (Walther et al. 2013). In this scenario, after substrate 
docking onto TatBC, TatA protomers are recruited to suit the size of the substrate in an 




Using TatAd, NMR data complemented this theory by highlighting the importance of its 
hinge region and its topology (Walther et al. 2010). The group enhanced the model by 
uncovering a Ôcharge zipper mechanismÕ (Walther et al. 2013)  Again based on TatAd, 
sequence charges suggested each TatA protein could be Ôzipped togetherÕ by 7 salt bridges; 
the length of the APH hairpin, which matched the lipid bilayer thickness.  Indeed, salt 
dependence for the translocase was reported (Van Der Ploeg et al. 2011), see Figure 8. 
 
However, now the Ôtranslocation pore modelÕ is less attractive for a multitude of reasons. 
The insertion of the APH into the bilayer was not found in other topological studies (Koch 
et al. 2012)(Aldridge et al. 2012) and solution NMR indicate the APH fans outwards from a 
central TMH core (Rodriguez et al. 2013). Also, low-resolution EM structures of a TatA 
homolog, TatE precludes its capability to possess a pore forming role as it is too small 
(Baglieri et al. 2012). Intriguingly, the unique translocase must therefore function 
otherwise. 
 
1.4.2 Membrane-destablisation model 
A second model proposes TatA complexes assemble and weaken/destabilise the lipid 
bilayer (Brser & Sanders 2003) and unlike the previous model, more recent topologies of 
TatA support this idea (Rollauer et al. 2012)(Rodriguez et al. 2013). Through molecular 
dynamic stimulations, Rodriguez et al pinpointed the destabilisation to the fact that TatA 
has a short TM domain. Fast forward five years and the theory was verified and enhanced 
with more information in E. coli in vivo (Hou et al. 2018).  
More specifically, in this model itÕs the N-terminal hydrophobic anchor of TatA that alone 
destabilises the membrane; its short length (as predicted) restricts the membrane thickness 
 
35 
to its own length, only 12 amino acids. However, this destabilisation only happens when a 
Tat substrate is bound. At resting state, when no substrate is bound, TatAÕs APH immerses 
itself into the membrane, elongating the membrane. As a consequence of substrate 
association, TatA re-orientates its APH (Lys24-Met43 and Asp 45-Lys49) outside of the 
membrane. TatAÕs rearrangement has been identified previously in thylakoids, its 
conformational transition of APH upon substrate induction is very similar which supports 
this data (Aldridge et al. 2012). 
 
The ÔswitchÕ from one state to the other is most likely also a consequence of the 
interactions between the substrate and TatAÕs APH. TatA does not recognise the 
synonymous ÔRRÕ motif, but TatAÕs APH does interact with the C-domain of the signal 
peptide (Taubert et al. 2015). Indeed, and in thylakoids, the APH and TatA have been seen 
interacting too (Pal et al. 2013) and with E. coli  evidence also demonstrates mature protein 
interacting with TatA (Alami et al. 2003)(Maurer et al. 2010)(Taubert & Brser 2014) . 
 
As a whole, this model cooperates with data regarding the TatBC complex (discussed 
above) and proposes both TatA and TatBC complexes work together synergistically on 
distinct regions of the transported Tat substrate. 
The Tat translocase is distinguished from other protein translocation systems (like Sec) due 
to the fact it exports fully folded proteins across the lipid bilayer. However other qualities 
also make the pathway unique such as its sole use of PMF for energy and its ability to 
Ôproof readÕ substrates to ensure theyÕre correctly folded.  These assets make Tat 









































Figure . The membrane destabilisation and translocation pore models. 
A. The TM of TatA (green) is very short, at resting state TatAÕs APH is tilted to elongate the complex and stabilise the membrane. When substrate binds TatB
(blue), the APHÕs N-terminal anchor switches position and immerses into the membrane, shortening the complex, causing membrane destabilisation so the substra
(red) can translocate.  B.  The APH of TatA is flexible, upon substrate binding it can fold into a hairpin stabilised by a cluster of intramolecular salt bridges (re
lines). TatAÕs together form a pore with polar residues at the APH, which constitute the inner lining of the pore and hence allow hydrophilic substrate passage.
Adapted from Patel  et al 2014.  36
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1.5 The Unique Tat pathway 
The Tat translocase is distinguished from other protein translocation systems (like Sec) due 
to the fact it exports fully folded proteins across the lipid bilayer. However other qualities 
also make the pathway unique such as its sole use of PMF for energy and its ability to 
Ôproof readÕ substrates to ensure theyÕre correctly folded.  These assets make Tat 
exploitation in the biotechnology industry appealing and will be discussed in below. 
1.5.1 Energy requirements  
A hallmark of the Tat system is that it is powered solely by the PMF and not nucleotide 
hydrolysis (ATP or GTP) like most other protein transportation machinery. PMF consists of 
a pH gradient (ΔpH) and the electric potential (Δψ) at the membrane (Mould et al. 1991). 
Early studies into the energetics of Tat were carried out in the plant thylakoid system, in the 
presence of light and ΔpH (but in the absence of nucleotides) the oxygen evolving Tat 
substrate was still exported (Mori & Cline 2002). In addition a phage shock protein PspA, 
involved in maintaining PMF, increased Tat translocation in bacteria (DeLisa et al. 2004). 
However, other studies in the green alga Chlamydomonas reinhardtii in vivo have shown 
the system can transport proteins without a thylakoidal ΔpH (Finazzi et al. 2003). With the 
knowledge that the Tat pathway can use both ΔpH and Δψ equally, this can be explained 
(Braun et al. 2007). As a consequence of this equivalency, the Theg group have suggested 
an antiporter mechanism where a coupling of H+ flow and protein transport has been 
suggested (Musser & Theg 2000).  ItÕs interesting to note the group also calculated the 
counterflow of protons necessary for Tat protein export, itÕs in the region of 7.9 x 104 
protons per molecule (Alder & Theg 2003).  This is equivalent to 10,000 ATP molecules, 
3% of the energy produced by chloroplast, so it is a considerable cost to the cell.  
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With regards to individual steps of the mechanism, the PMF is not required for protein 
targeting or protein binding to TatBC, but is required for more advanced binding stages and 
the oligomerisation of TatA (Grard & Cline 2007) (Alami et al. 2003). For thylakoids, the 
ΔpH component of PMF could protonate TatA at Glu10, making it energetically feasible to 
move up in the membrane to its docking site on TM4 and hydrogen-bond with TatC (Gln-
234) (Aldridge et al. 2014). ItÕs more unclear how the assembly of TatA in E. coli is 
facilitated by PMF as itÕs been shown largely, if not entirely, the transport energy driving 
force is from Δψ alone (Bageshwar & Musser 2007). Indeed, the in vitro study concluded 
two distinct Δψ steps allowed transport, one ∆ψ of relatively high magnitude that may be 
short-lived and a second ∆ψ requiring step minimally requires a long duration, but 
relatively low magnitude ∆ψ. If ∆ψ was increased, so was transport speed. This begs the 
question, how does the mechanism work and why is it different to thylakoid data? Perhaps 
these inverted membrane vesicles (IMVÕs) (Alami et al. 2003) are missing something as the 
nature of Δψ and protein export by Tat (not least in E. coli) remains unclear. A reasonable 
scenario is that movement of certain charged regions within Tat proteins could be induced 
by a ∆ψ, but more research is required in this area. 
 
1.5.2 Proofreading and Quality control 
Another feature of the Tat pathway is its quality control, proofreading ability. Tat substrates 
only can exit the cytosol once they are fully folded and (if necessary) contain their allocated 
cofactor. This complicated task requires the aid of specific chaperones known as Redox 
Enzyme Maturation Proteins (REMPs) (Turner et al. 2004). An example Tat substrate with 
a REMP is the oxidoreductase trimethylamine-N-oxide (TMAO) reductase (TorA); it is 
encoded by the torCAD operon. torA encodes the TMAO reductase, torC encodes its haem-
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binding quinol oxidase and torD is its REMP. REMPs often dimerise and bind to their 
cognate partner via the C-domains of its signal peptide (Tranier et al. 2002). The role of 
TorD, like most specific chaperones, is to block the AXA cleavage site (to prevent 
premature protein degradation), coordinate cofactor assembly and foresee other maturation 
steps such as membrane targeting and interaction (Chan et al. 2009). This coordination 
occurs until the apo-pre-protein interacts with Tat machinery. As Tat substrates are 
especially complex, to ensure malfunctioning proteins are not exported, the Tat complex 
rejects and sometimes even degrades the protein within the cytosol (Halbig et al. 
1999)(Delisa et al. 2003)(Matos et al. 2008). To note, the thylakoid Tat system seems to 
have a less stringent ÔproofreadingÕ system as unfolded proteins are imported (Hynds et al. 
1998). The quality control exhibited by the E. coli Tat pathway is highly unusual; hence 
different approaches have investigated when and how it happens.  
 
Cofactor insertion has been explored in Tat proofreading. Native E. coli Tat substrates 
NrfC and NapG were mutated to prevent their central cofactor FeS binding, indeed this 
alteration blocked export (Matos et al. 2008). The B. subtilis Rieske iron-sulphur substrate 
QcrA was mutated too, to either stop cofactor binding or disulphide formation (Goosens et 
al. 2014). A proofreading hierarchy was uncovered; mutantÕs defective in disulphide 
bonding were quickly degraded, whereas those defective in cofactor binding accumulated 
in the cytoplasm and membrane. Two heme-binding proteins have also been tested, 
cytochrome C required heme insertion for export (Sanders et al. 2001) and another heme 
binding protein, the synthetic BT6 maquette showed interesting results. The latter binds 2 
hemes and is tested with a TorA signal peptide. Histidines were mutated into alanines to 
prevent heme binding, if no hemes bound, the protein was not exported, one heme bound 
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allowed some protein export, whereas if two hemes bound, good export was seen 
(Sutherland et al. 2018). These findings suggest Tat can sense the protein conformational 
stability. 
 
Conformational stability has been studied in vivo and in vitro using non-native Tat 
substrates (PhoA, scFv and a Fab fragment). These proteins only exported in oxidising 
conditions (Cox strains) when their disulphide bonds could form (Delisa et al. 2003). 
However in another study some proteins (hGH, scFv and IFN) without their disulphides 
formed were exported to the periplasm (Alanen et al. 2015). hGH at least can form a near 
native state in the absence of  its two disulphide bonds. This resembles the protein CueO, it 
can export without its cofactor copper, but UV CD shows CueO without copper is nearly 
structurally identical to CueO with copper (Stolle et al. 2016).  
 
Several studies in both bacteria and plants have used varying lengths of FG repeats from 
the yeast nuclear pore protein Nsp1p; they intrinsically lack structure and are hydrophilic. 
Fused to a Tat signal peptide, early export results demonstrated that with increasing protein 
length, translocation efficiency decreased, 100-120 amino acids was tolerated but a short 
hydrophobic stretch stopped export (Cline & McCaffery 2007)(Richter et al. 2007). 
Unstructured linkers have also been placed between the signal peptide and the N-terminus 
of a mature Tat substrate, surprisingly an unstructured linker length of 110 amino acids was 
exported (Lindenstrau§ & Brser 2009). However, the degree of instability and 
hydrophobicity the Tat system will tolerate had never been investigated with a well 
characterised test protein. 
A study used scFv mutants (which were structurally defined) to identify what Tat 
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recognised as ÔunfoldedÕ and rejected for export (Jones et al. 2016). Tat tolerated 
significant changes in hydrophobicity and charge but did not export the scFv with an 
unstructured tail or without disulphide bond formation via CyDisCo. CyDisCo comprises 
of yeast mitochondrial thiol oxidase, Erv1p and human protein disulfide isomerase (PDI) 
that confer the ability to catalyse cytoplasmic disulphide bonds. In conclusion therefore the 
study indicated proofreading has evolved to sense conformational flexibility and detect 
even very transiently exposed internal regions. 
 
Although itÕs still unclear what the Tat complex rejects as misfolded, the major question 
arises, how does the Tat complex reject the proteins? Tat proteins, misfolded or not, both 
interact with the Tat translocase, for example the native Tat substrate PhoA has been co-
purified with TatBC (Richter & Brser 2005). This gave rise to the idea Tat does not 
innately have an inbuilt ÔproofreadingÕ mechanism, but an efficient degradation system 
clears the Tat translocase. However, site specific photo cross-linking revealed perturbed 
interaction between the signal peptide and the misfolded protein as if the substrate was not 
correctly inserted into the binding socket, although physical interaction took place 
(Panahandeh et al. 2008). 
 
Other approaches have looked into the Tat translocon too. Quality Control Suppression 
mutants (QCS) were used to screen mutations within the TatABC which gave rise to less 
stringent proofreading (Rocco et al. 2012). Synthesised using 3-helix-bundles with various 
conformational flexibilities fused to TEM-1 β-lactamase, key residues were identified. The 
majority of the QCS mutations were confined to the unstructured or loop regions of 




1.5.3 The Biotechnology Industry 
The ability of Tat to export fully folded proteins to the periplasm and proofread they are 
correctly folded is advantageous in the Biotechnology industry. High value therapeutic 
proteins produced via Tat can be exported and processed to their mature state with high 
homogeneity.  
 
E. coli is already used as a host organism for protein production, owing to its rapid growth, 
high yield, ease of scale up and cost-effectiveness, around 30% of biotherapeutics are 
synthesised in bacteria (Overton 2014). The standard location of recombinant protein 
accumulation is in the cytoplasm, however this is not ideal due to its reducing environment, 
high levels of proteases and high numbers of contaminating proteins. An alternative method 
used in industry involves the Sec system (described in Section 1.2), protein is exported to 
the oxidising periplasm with an N-terminal signal peptide. This alternative approach 
decreases chances of proteolysis and eases downstream purification as the periplasm only 
contains 4% of the proteome (Pooley et al. 1996). Usually, proteins are released from the 
periplasm by osmotic shock, similar to Section 2.4.2 (French et al. 1996). The Sec system, 
however, does not export folded proteins and it cannot export proteins that fold rapidly in 
the cytoplasm, such as GFP. 
 
TorA- GFP was expressed in E. coli and found to export via the Tat system, as proof of 
concept that Tat can export proteins to the periplasm Sec cannot (Barrett et al. 2003). 
Biotherapeutics can too be exported via the Tat pathways, especially with the aid of 
CyDisCo which catalyses disulphide bond formation in the cytoplasm (Matos et al. 
2014)(Alanen et al. 2015). More recently, Tat was overexpressed from the chromosome 
 
43 
(with a pTac promoter) to engineer TatExpress cells during fermentation, a 5 fold increase 
of hGH was found in the periplasm compared to wildtype cells (Browning et al. 2017).  
 
The Ôgold standardÕ of bacterial protein production, protein secretion to the media, was 
successfully achieved when Tat B. subtilis TatAdCd was expressed in ΔtatABCDE strains 
(Albiniak et al. 2013).  In batch fermentation ~90% of GFP was present in the medium as 
mature protein after 16 hours of fermentation. The cells were otherwise intact and export 
levels were found to be about 0.35 g.L-1. This release resembles both mammalian and yeast 
systems (Kim et al. 2012)(Mattanovich et al. 2012) but without the considerable time and 
cost implications. Current efforts are focused on testing different biotherapeutics and 




1.6 Aims of this project 
The primary aim of this investigation is to develop and understand a novel means of 
exporting recombinant proteins to the periplasm of E. coli via the Tat translocase. The 
experiments utilised both the Gram-negative E. coli TatABC translocase and two minimal 
Gram-positive TatAC translocases, TatAdCd and TatAyCy. To achieve this overall aim a 
series of questions and tests were explored: 
 
1. Which biopharmaceutical recombinant proteins will TatAdCd export? 
2. How does the Gram-positive Tat translocase compare to the Gram-negative translocase, 
in terms of proof-reading ability? 
3. Which orientations and conditions does Tat prefer for scFv (and possible diabody) export 
to periplasm? Can this be scaled up to fermentation? 
4. As the E. coli and B. subtilis Tat systems are so distinctive, can I use a novel means of 
membrane protein purification (SMA) to purify the smaller Gram-positive Tat complexes? 






2. Materials and Methods 
2.1 Suppliers of chemicals, reagents and equipment used 
All reagents, materials and equipment were obtained from the companies listed below. 
 
Beckman Coulter Inc (USA): TL-100 Ultracentrifuge TLA 100.2 rotor; Avanti J-25, JA10 
rotor; DU 730 UV/Vis Spectrophotometer 
Bio-Rad (USA): Agarose; Bio-Rad gel doc; Bio-Rad Mini-PROTEAN¨ Tetra System; 
Acrylamide (15%, 0.3% bis-acrylamide, 37:5:1); Coomassie Brilliant Blue R-250;  
Claritytm Western ECL substrate; T1000TM Thermo Cycler PCR machine  
Eppendorf: 1.5 mL centrifuge tubes; PCR tubes; Centrifuge 5417R; pipette tips 
Eurofins (UK): OligoÕs/Primers 
Fisher Scientific (UK): Anti-his (C-term) unconjugated antibody; dNTP nucleotide mix; 
GeneRuler (100 bp and 1 kb); Mircobiological spreaders; Inoculation loops; Nanodrop 
2000c 
Formedium (UK): PBS 
GE healthcare (UK): Superdex 200 10/300GL prep-packed gel filtration column; ECLTM 
detection reagents; IMACTM sepharose 6 fastflow; VivaspinTM protein concentration spin 
column; PVDF and nitrocellulose membrane 
GenPure: UV/UF water purification system for MilliQ H2O 
Gilson: Pipettes, P2, P20, P200, P1000 
Grant: Heat block;  SUB Aqua 12 Plus water bath 
Greiner Bio-one: Universals; Easy load tips; 
IBA Lifescienes: Anti-strep HRP conjugate; 
Infors (Switzerland): Multitron Pro shaking incubators; Minifors 2 fermenters 
Invitrogen (USA): Anti-hexahistidine (C-term) conjugated; 
Life technologies (USA): BSA 
MSE: Soniprep 150 plus 
New England Biolabs (UK): Phusion high fidelity DNA polymerase (2U/ µL) ; 
Restriction enzymes; NEB¨ Turbo compotent cells; NEB¨ BL21 DE3 competent cells; 
Coloured protein standard broad range(11-245 kDa) 
Panasonic: Heated static incubator 
Promega (UK): dNTP mix (200µM); Anti-mouse HRP conjugate; Anti-rabbit HRP 
conjugate 
Qiagen (Germany): QIAprep Spin Miniprep Kit; QIAprep Gel Extraction Kit 
Roche applied science (UK): CompleteTM protease inhibitor tablets; T4 DNA ligase 
Sarstedt: Serological pipettes; 15 mL and 50 mL falcon tubes; Petri-dishes 92x16 mm; 
Filter tips; curvettes 
Sigma-Aldrich (UK): Lysozyme; Anti-flag HRP conjugate 
Starlab: Starguard comfort gloves; 
Thermo Fisher Scientific Inc (USA): Nanodrop 2000c; Megafuge 16R Centrifuge, 




2.2 DNA techniques 
2.2.1 Preparation of plasmid DNA 
Plasmids were purified using the Qiagen QIAprep Spin Miniprep Kit as per the 
manufacturerÕs instructions. Plasmids were eluted in 50 µL elution buffer (10 mM Tris-Cl 
pH 8.5) with their concentration determined using the Nanodrop. 
 
2.2.2 Amplification of DNA via Polymerase Chain Reaction 
PCRÕs were achieved using Bio-Rad T100TM Thermal Cycler machine. Each reaction 
contained, 1 µL template DNA (80-100 ng), 0.5 µL Phusion high fidelity DNA polymerase, 
1 µL dNTP mix, 1.5 µL DMSO (3%), 10 µL GC buffer (10%), 0.5 µL of forward and 
reverse primer (0.5 µM) made up to 50µL with autoclaved milliQ H2O.  
 
An example cycle is given below: 
Initial denaturation 98¡C  30 sec   
Denaturation 98¡C  10 sec   
x 25 cycles Annealing Primer Tm 30 sec 
Extension 72¡C   30 sec 
Final extension 72¡C   5 mins   








Sequence 5Õ à  3Õ 
 
TatAdCd study 
preFhuDF  GCATATGAATTCATGAGCGGCTTACCTC  
preFhuDR GGTACGCTGCAGTCACGCTTTACCTCCGATG  
 





















































2.2.4 Agarose gel electrophoresis 
Agarose gels were prepared by adding 1% (w/v) agarose into 1 x TAE buffer (0.04 M Tris-
acetate, 0.001M EDTA, pH 8.2). Typically 0.5g aragrose and 50 mL 1 x TAE buffer were 
put into a conical flask and microwaved for 1 min until the agarose had dissolved.  The 
solidified gel was then placed in the tank, submerged in 1 x TAE buffer. DNA samples 
(including the DNA marker) were mixed with SYBER Green Nucleic Acid Gel stain and 6 
x Gel loading buffer. Electrophoresis was carried out at 120V for 45 mins and was 
visualised using Bio-Rad Gel doc. 
 
2.2.5 Purification of DNA from Agarose gels 
Appropriate bands were excised from agarose gels under UV transilluminescence using a 
scalpel blade. DNA was recovered from the agarose gel using Quigen QIAprep Gel 
Extraction Kit as per the manufacturerÕs instructions. DNA was eluted in 30 µL elution 
buffer (10 mM Tris-Cl pH 8.5) with their concentration determined using the Nanodrop. 
 
2.2.6 Restriction Digests of DNA  
Typically, 2 µg DNA was mixed with 5 µL 10 x CutSmart (or appropriate) NEBuffer, 
20units (generally 1 µL) of one or two enzymes and the total reaction volume was made to 
50 µL with autoclaved MilliQ water. The reaction was then incubated for 1 or 2 hours at 




Enzyme name Sequence 5Õ à  3Õ 





NheI HF G-CTAGC 
SacHI HF GAGCT-C 
SalI G-TCGAC 
Table 3. Restriction enzymes used in this study 
 
2.2.7 Ligation of DNA fragments into plasmid vector backbone 
DNA fragments were cloned into vectors with 1 µL T4 D NA ligase, 1 µL 10 x ligase 
buffer and an insert to vector concentration ratio of 3:1 (typically to make a 10 µL reaction 
mix).  The ligation incubation was either carried out at 2 hrs RT or 0/N at 4¡C before 
transformation. 
 
2.2.8 Sequencing of plasmid DNA 
All sequencing was carried out using GATC sequencing service. 5 µLpurified plasmid 
(typically 100 ng) was mixed with 5 µL  (5 mM) sequencing primer. 
Primer name  Sequence 5Õ à 3Õ 
pTac_F GAGCGGATAACAATTTCACACAGG 
pBAD_F TATGCCATAGCATTTTTATCC 
Table 4. Sequencing primers used in this study 
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2.2.9 Constructs used in this study 
Plasmid 
name 
Function Tag Reference 
pCM233 pLysBAD TatABC Strep  This study 
pCM232 pLysBAD TatAdCd Strep (Albiniak et al. 2013) 
pKF14 pBAD24 TatAyCy H10 This study 
pKF9 pBAD24 TatE H10 This study 
PKRK40c pBAD24 Erv1p and hPDI (CyDisCo) Flag This study 
pHA17 pET23/pTac TorA-scFvO  H6 (Alanen et al. 2014) 
pHA15 pET23/pTac TorA-IFN  H6 (Alanen et al. 2014) 
pHA14 pET23/pTac TorA-hGH H6 (Alanen et al. 2014) 
pHA23 pET23/pTac TorA-VH H6 (Alanen et al. 2014) 
pHAK13 pET23/pTac TorA-scFvM wild-type + 
CyDisCo 
H6 (Jones et al. 2016) 
pAJ15 pET23/pTac TorA-scFvM wild-type H6 (Jones et al. 2016) 
pAJ5 pET23/pTac TorA-3SB (L11Q, Q13K, 
A88E, L112K, T114E, S116 K)  + 
CyDisCo 
H6 (Jones et al. 2016) 
pAJ6 pET23/pTac TorA-5Lys (L11 K, Q13K, 
A88K, L112K, S116 K) + CyDisCo 
H6 (Jones et al. 2016) 
pAJ7 pET23/pTac TorA-5Glu (L11E, Q13E, 
A88E, L112E, S116E)  + CyDisCo 
H6 (Jones et al. 2016) 
pAJ8 pET23/pTac TorA-1SB (L112K, T114E 
+ CyDisCo 
H6 (Jones et al. 2016) 
pAJ9 pET23/pTac TorA-5R > K (R19K, 
R87K, R150K, R203K, R240K) + 
CyDisCo 
H6 (Jones et al. 2016) 
pAJ10 pET23/pTac TorA-7 K > R (K65R, 
K76R, K162R, K183R, K186R, K235R, 
K239R) + CyDisCo 
H6 (Jones et al. 2016) 
pAJ11 pET23/pTac TorA-P172S (P172S) + 
CyDisCo 
H6 (Jones et al. 2016) 
pAJ24 pET23/pTac TorA-2SB (A88E, L112K, 
T114E, S116K) + CyDisCo 
H6 (Jones et al. 2016) 
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pAJ31 pET23/pTac TorA-4NLeu (Q13L, 
R19L, K65L, K76L) + CyDisCo 
H6 (Jones et al. 2016) 
pAJ35 pET23/pTac TorA-5Arg (L11R, Q13R, 
A88R, L112R, S116R) + CyDisCo 
H6 (Jones et al. 2016) 
pAJ36 pET23/pTac TorA-5NLeu (Q13L, 
R19L, K65L, K76L, A88L) + CyDisCo 
H6 (Jones et al. 2016) 
pAJ39 pET23/pTac TorA-6NLeu (Q13L, 
R19L, K65L, K76L, A88L, S116L) + 
CyDisCo 
H6 (Jones et al. 2016) 
CM1 pBAD24 preNrfC H6 (Matos et al. 2008) 
CM11 pBAD 24 preFhuD H6 This study 
pKF15 pEXTII TorA 001VH-VL H6 This study 
pKF16 pEXTII TorA-002 VH-VL (DS) H6 This study 
pKF17 pEXTII TorA-003 VH-VL Short linker H6 This study 
pKF18 pEXTII TorA-004 VH-VL Short linker 
(DS) 
H6 This study 
pKF19 pEXTII TorA-005 VL-VH H6 This study 
pKF20 pEXTII TorA-006 VL-VH (DS) H6 This study 
pKF21 pEXTII TorA-007 VL-VH Short linker H6 This study 
pKF22 pEXTII TorA-008 VL-VH Short linker 
(DS) 
H6 This study 
pKF23 pEXTII TorA 001VH-VL + CyDisCo H6 This study 
pKF24 pEXTII TorA-002 VH-VL (DS) 
+CyDisCo 
H6 This study 
pKF25 pEXTII TorA-003 VH-VL Short linker 
+ CyDisCo 
H6 This study 
pKF26 pEXTII TorA-004 VH-VL Short linker 
(DS) + CyDisCo 
H6 This study 
pKF27 pEXTII TorA-005 VL-VH +CyDisCo H6 This study 
pKF28 pEXTII TorA-006 VL-VH (DS) 
+CyDisCo 
H6 This study 
pKF29 pEXTII TorA-007 VL-VH Short linker 
+ CyDisCo 
H6 This study 
pKF30 pEXTII TorA-008 VL-VH Short linker 
(DS) +CyDisCo 
H6 This study 
Table 5. Constructs used in this study 
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Strain Genotype Reference/source 
MC4100 AraR, F2 arD139 DlacU169 rspL150 
relA1 flB5301 deoC1 ptsF25 rbsR 
(Barrett, Ray, et al. 
2003)  








fhuA2 [lon] ompT gal (λ DE3) [dcm] 
∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 




TatExpress BL21 BL21 carrying a pTac promotor 
upstream of tatABCD 
 




F' proA+B+ lacIq ∆lacZM15 
/ fhuA2  ∆(lac-proAB)  glnV galK16 
galE15  R(zgb-210::Tn10)TetS  endA1 
thi-1 ∆(hsdS-mcrB)5  
 
NEB¨ 
Table 6. E.coli strains used in this study 
 
2.3 Maintenance of E. coli cultures 
2.3.1 Media and supplements 
Most liquid cultures were grown in LB medium, although other mediaÕs were used too, see 
table 7. LBA (LB with the addition of 10 g/L bacto-agar) was used for growth on plates. 
All were supplemented with appropriate antibiotic. Ampicillin (100 µg/mL) and 
Kanamycin (50 µg/mL) were dissolved in water whereas Chloramphenicol (35 µg/mL) was 





LB 10 g/L sodium chloride, 10 g/L tryptone, 5 g/L yeast extract 
TB 24 g/L yeast extract, 12 g/L tryptone, 4 mL/L glycerol 
Potassium phosphate buffer: K2PO4 12.5 g/100mL and KH2PO4 g/100mL 
AIM 10 g/L tryptone, 5 g/L yeast extract, 3.3 g/L (NH4)2s04, 6.8 g/L KH2PO4, 
7.1 g/L Na2HPO4, 0.5 g/L glucose, 2 g/L lactose, 0.15 g/L MgS04 
PY 48 g/L phytone, 30 g/L yeast extract, 5 g/L NaCl 
SM6 10 mL 10X SM6 trace elements, 95 g/L glycerol, 5.2 g/L (NH4)SO4, 4.4 
g/L NaH2PO4.H2O, 4.16 g/L citric acid, 4.03 g/L KCl, 1.04 g/L 




104 g/L citric acid, 10.06 g/L FeCl3.6H2O, 5.22 g/L CaCl2.H2O, 2.72 g/L 
MnSO4.7H2O, 2.06 g/L ZnSO4.4H2O, 0.81 g/L CuSO4.5H2O, 0.42 g/L 
CoSO4.7H2O, 0.03 g/L H3BO3, 0.02 g/L Na2MoO4.2H2O 
Table 7. MediaÕs used and their components  
 
2.3.2 Transformation of competent E. coli cells 
The E. coli strains listed in table 5 were inoculated in 5 mL LB media and cultured O/N at 
37¡C, 200rpm. The following morning, 100 µL of the pre-culture was inoculated into 10 
mL of fresh LB media and incubated in the same conditions until OD600 reached 0.4- 0.5. 
Cells were harvested via centrifugation at 3000 rpm, 4¡C for 10 mins. Supernatant was 
discarded and cell pellet was re-suspended in 10 mL ice-cold 100 mM MgCl2, then left to 
incubate on ice for 5 mins. Cells were again harvested as described previously. Supernatant 
was discarded and cell pellet was re-suspended in 1 mL ice-cold 100 mM CaCl2, then left 
on ice for 1 hr or in the fridge O/N.  
To transform, on ice, 50 µL of competent E. coli cells were incubated with 2 µL DNA (100 
ng/uL) for 30 mins. The cells were then heat shocked at 42¡C in the water bath for 30 secs 
and immediately placed back on ice for 5 mins. Cells recovered in 200 µL LB media for 1 
hr at 37¡C, 200 rpm and plated on LBA with appropriate antibiotics. These were placed 
inverted O/N in the plate incubator, set at 37¡C. 
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2.3.3 Storage of E. coli cells 
Glycerol stocks of E. coli cultures were prepared by mixing 2 parts 50% glycerol with 1 
part stationary phase culture, stored in the -80¡C freezer. 
 
2.4 Protein production and E. coli cell fractionation 
2.4.1 Cell culture and induction of plasmids 
A 5 mL pre-culture of E. coli cells with appropriate plasmid and antibiotic were grown O/N 
at 37¡C, 200 rpm. The following morning, cultures were diluted to OD 0.05 with fresh LB 
media (or other media if stated) and appropriate antibiotic. Typically, 50 mL culture was 
used to culture E. coli cells in a 250 mL Erlenmeyer flask at 37¡C, 200rpm until 0D600 
reached 0.4 Ð 0.6 (stationary phase). Plasmid(s) were then induced and kept in the same 
conditions as pre-induction. pYU49 (pET23/pTac) and pEXT22 were typically induced 
with 0.5 mM IPTG, whereas pBAD24 was typically induced with 0.5 mM arabinose, unless 
otherwise stated. AIM tests were never induced with IPTG. 
 
2.4.2 E. coli fermentation 
A 50mL pre-inoculant of PY media (with appropriate antibiotic) were grown for 6 hours at 
37¡C, 250 rpm. 1 mL of pre-inoculation was transferred to 200 mL of SM6 fermentation 
media to grow the pre-culture O/N at 30¡C, 200 rpm. The volume equivalent to 300 OD/L 
inoculated the fermenters when timings suited.  
The fermenter was clean and autoclaved with 500 mL SM6 media and all probes (pH, 
temperature, pO) inside. Temperature was set to 30¡C and sustained via a chiller. Whilst 
pH was set to pH 7 and kept constant by 25% sulphuric acid base 25% ammonia; 
connection lines were too primed. The pO probe was calibrated by maxing the stirrer and 
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airflow. A cascade was set so when pO2 reached 30%, the stirrer was activated (800-1600 
rpm) and then total flow (1.5 0 2 L/min). When both stirrer and airflow were maxed, 
culture temperature was dropped to 25¡C approximately 15 hrs post inoculation. At specific 
ODÕs, different supplements were given or induction occurred: 
OD 38-42: 8 ml/L 1M MgS04.7H2O 
OD 54-58: 5 ml/L 232.8 g/L NaHPO.H2O 
OD 66-70: 7 ml/L NaHPO.H2O and start glycerol feed (80% w/w glycerol at a rate of 
0.35% pump capacity 
>OD 75: Induce with 9 ml/L of 4. 31 g/L IPTG (made fresh) 
Cell fractionation took place pre and post induction at different time points while 
fermentation growth was monitored.  
 
2.4.3 E. coli cell fractionation  
Cells were fractionated into periplasm, cytoplasm and membrane fractions using the 
osmotic/cold shock method as described (Randall & Hardy 1986). Post induction, protein 
expression occurred for typically 3 hrs, until cells equal to 0D600 were harvested via 
centrifugation at 3000 rpm, 4¡C for 10 mins. Samples were placed on ice, supernatant was 
discarded and cell pellet was resuspended in 0.5 mL ice cold Buffer 1 (100 mM Tris-acetate 
pH 8.2, 500 mM sucrose, 5 mM EDTA). 0.5 mL ice cold MilliQ H2O was added followed 
by 40 µL lysozyme (1 mg/mL stock) and incubated on ice for 5 mins. To stabilise the inner 
membrane, 20 µL MgCl2 (1M stock) was added prior to centrifugation at 14,000 rpm, 4¡C 
for 2 mins. 0.5 mL of supernatant was collected as the periplasmic fraction. Remaining 
supernatant was discarded and the pellet was washed with 1 mL ice cold Buffer 2 (50mM 
Tris-acetate pH 8.2, 250 mM sucrose, 10 mM MgS04) prior to centrifugation at 14,000 rpm, 
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4¡C for 5 mins. All supernatant was discarded and pellet was resuspended in Buffer 3 
(50mM Tris acetate pH 8.2, 2.5mM EDTA). Sonication (10 secs on/ 10 secs off x 3) at 8 
µM ensured full cell lysis. Ultracentrifugation at 70,000 rpm, 4¡C for 30 mins separated the 
spheroplast. 0.5 mL supernatant was collected as the cytoplasmic fraction and the 
remaining was discarded. The pellet was resuspended in 0.5 mL Buffer 3 and collected as 
the membrane fraction. All fractions were stored at -20¡C with and without Protein Gel 
Loading Buffer. 
 
2.4.4 Membrane isolation and solubilisation for Tat purification  
For a 0.4L culture, Δ tat cells expressing Tat (for 3 hrs) were harvested by centrifugation at 
3,000 rpm, 4¡C for 30 mins. E. coli cells were resuspended in 24 ml pre-chilled Disruption 
buffer (100 mM Tris-acetate pH 8.2, 500 mM sucrose and 5 mM EDTA) with 1 protease 
inhibitor tablet added to the suspension. To disrupt the E. coli outer membrane, 1 mg/ml 
lysozyme was added, followed by immediate addition of ice-cold dH2O and 1 ml of 1M 
MgS04. The spheroplasts were harvested by centrifugation at 3,000 rpm, 4¡C for 20 mins 
and resuspended in 10 mL Sonication buffer (50 mM tris-acetate pH 8.2 and 2.5 mM 
EDTA). Sonication (30 secs on/ 30 secs off x 5) at 8 µM ensured full cell lysis and 
ultracentrifugation at 70,000 rpm, 4¡C for 30 mins separated the spheroplast. The resulting 
membrane pellet was solubilised in SMA solubilisation buffer (50 mM Tris-HCl pH 8.0, 
500 µM NaCl and 10% Glycerol). 
 
2.4.5 Membrane SMA solubilisation  
The resulting membrane pellet was solubilised in SMA solubilisation buffer (50 mM Tris-
HCl pH 8.0, 500 mM NaCl and 10% Glycerol). 2.5% (w/v) SMA polymer was added and 
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incubated for 2 hrs at RT. SMA polymer was synthesised as described (Lee et al. 2016). 
The insoluble fraction was removed by centrifugation at 44, 000 rpm, 4¡C for 1 hr.  
2.5 Protein purification 
2.5.1 Nickel column purification 
Supernatant from the final step in SMA solubilisation was incubated O/N at 4¡C with 
IMAC SepharoseTM 6 Fast Flow beads in a column. The column was made with charged 
beads (0.2 M NiCl), glass wool that acted as a filter and was equilibrated with 3 CV SMA 
solubilisation buffer. The following day, FT was collected and unbound matter was 
removed with an increasing imidazole gradient (0.5 mM, 20mM, 60mM and 200 mM). 
Each concentration wash was 2 CV and collected as W. 6x histidine-tagged protein was 
eluted and collected in 5 x 1 mL fractions using 0.5 M imidazole. The column was washed 
stripped to remove all residual protein with 2 CV 100mM EDTA and stored in 20% 
ethanol. The appropriate elution fraction as visualised by SDS-PAGE Coomassie stain in 
Section 2.6.2 was then taken forward for SEC. 
 
2.5.2 Gel-filtration chromatography 
Size exclusion chromatography was used as a final purification step to isolate the Tat 
proteins. A Superdex200 10/300 GL column with a protein separation range of 10-600 kDa 
was used with an KTAª FPLC system (operated by UNICORN¨ v.4.00 software). The 
column was equilibrated and ran with 2CV Gel filtration buffer (50mM Tris and 150mM 
NaCl). The sample was centrifuged at 10,000 rpm, 4¡C for 10 mins prior to loading. 
Column flow was usually 0.5 mL/min and elutionÕs were collected in 0.5 mL fractions. 
Between runs, the column was washed with MilliQ, sometimes stripped with 1 M NaOH 
and stored in 20% ethanol according to the manufacturerÕs guide. 
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2.6 Protein electrophoresis 
2.6.1 SDS poly-acrylamide gel electrophoresis (SDS-PAGE) 
Gel electrophoresis was used to resolve protein samples, carried out using vertical gel 
apparatus from Bio-Rad Mini-PROTEAN¨ Tetra System, gels were ran and cast according 
to the manufacturerÕs instructions. 0.75 mm gels were made from a separation and a 
stacking gel. Separation gel was composed of 15% acrylamide, 0.3% bis-acrylamide 
(37:5:1), 375 mM Tris-HCl pH 8.85, 0.1% SDS, 0.1% APS and 0.06% TEMED. Staking 
gel was composed of 5% acrylamide, 0.0375 % bis-acrylamide, 125 mM Tris-HCL pH 6.8, 
0.001% SDS, 0.6% APS and 0.06% TEMED. Before loading, samples were mixed with 
protein gel loading buffer (125 mM Tris-HCl pH 6.8, 20% glycerol, 4% SDS, 0.02% 
bromophenol blue and 5% β- mercaptoethanol) and heated for 10 mins at 50¡C. Gels were 
ran at 60 mA for typically 40 mins in protein gel running buffer (25 mM Tris, 192 mM 
Glycine and 0.1% SDS at pH 8.3). 
 
2.6.2 Coomassie staining 
Proteins were visualised on SDS-PAGE by incubation with 50 mL Coomassie stain (10% 
acetic acid, 40% methanol and 1 g/L Coomassie blue) for 1 hr at RT and rocking. The stain 
was removed from the background by incubation by D-stain (5% ethanol, 7.5% acetic acid) 
for up to 8 hours, RT and rocking.  
 
2.7 Protein detection  
2.7.1 Western-blotting 
A parallel SDS page was also run via electrophoresis for a wet-western blot, which 
visualised C-terminal hexa-histidine residues. To transfer proteins onto PVDF membrane, 
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the SDS-PAGE was placed on top of the membrane (post activation with methanol). This 
was sandwiched between two sheets of Whatman paper and two sponges, presoaked in 
Western blot transfer buffer (192 mM Glycine, 25 mM Tris and 10 % ethanol) placed in a 
cassette between electrodes. The tank was filled with Western blot transfer buffer while 
proteins were transferred at 80 V for 1 hr.   
 
2.7.2 Immunoblotting 
The PVDF membrane was blocked overnight at 4¡C in a solution containing 2.5% 
skimmed milk powder in 1X PBS-T, the following was carried out at RT on a shaking 
table. Membranes were washed for 3 x 5 mins PBS-T before the incubation of primary 
antibody for 1 hr. Then, the membrane is washed again for 3 x 5 mins PBS-T before the 
incubation of the appropriate secondary antibody for 1hr. Finally, the membrane was 
washed 8 x 5 mins before imaging. For more information on antibodies, see Table 6. 
Immunoreactive bands were detected using the ECLTM kit according to the manufactureÕs 
guide and the bands were visualised using BioRad Gel-doc chemiluminescence imager with 
associated software. 
Antibody Concentration Source 
Anti-hexahistidine (C-terminal) 1: 8,000 Invitrogen 
Anti-mouse HRP conjugate 1: 5,000 Promega 
Anti-strep HRP conjugate 1: 32,000 IBA life sciences 
Anti-Ay 1: 2,000 Jan Maarten van Dijl 
Anti-flag 1:8,000 Sigma 
Anti-rabbit HRP conjugate 1: 5,000 Promega 
Table 8. Antibodies used in this study 
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2.8 Protein imaging  
2.8.1 Negative staining  
5 µl of purified TatAyCy-SMALP was pipetted onto a freshly glow-discharged 
Formvar/carbon coated copper grid (300 mesh), for 1 min. Washing excess sample off the 
grid was achieved by touching the grid to the convex face of a 8 μl drop of GF buffer for 
~10 secs with gentle agitation. Post-washing, excess liquid was removed from the grid by 
blotting with filter paper. This process of washing and blotting was repeated again. Next, 
the grid was washed for ~10 secs in an 8 μl drop of uranyl acetate stain (1 or 2% (w/v)) 
before blotting and staining in a fresh drop of uranyl acetate for 20 secs. The grid was 
blotted for a final time and then left to air dry for ~10 min before insertion into the electron 
microscope. This protocol is an adaptation of a previously published method (Rubinstein, 
2007) using a Parafilm¨ drop support and Whatman¨ paper for blotting.  
 
Negative stain data was collected on a JEOL 2100Plus at nominal magnification of 60 
000X with a pixel size of 1.84 .  
 
2.8.2 Cryogenic plunging of biological samples   
Cryogenic samples of TatAyCy-SMALP were prepared using the Leica automatic freeze 
plunger: EM GP 2. 3 µl of purified TatAyCy-SMALP was pipetted onto a freshly glow-
discharged Quantifoil grid (1.2 µm dia x 1.3 µm 300 mesh) and blotted for 6 seconds in an 




2.9 Transmission electron microscopy (TEM)  
2.9.1 JEOL 2100Plus  
200 kV JEOL transmission electron microscope with a LaB6 electron source. Fitted with a 
Gatan OneView IS camera. The microscope was controlled by JEOL TEM Center 
(ver.1.7.11.1834) and the OneView camera was operated using Gatan Digital Micrograph 
software (ver.3.22.1461.0).      
 
2.9.2 JEOL 2200FS   
200 kV JEOL transmission electron microscope with a field emission gun electron source. 
Fitted with an in-column energy filter and Gatan K2 Summit direct electron detector. The 
microscope was controlled by JEOL SightX software (ver.1.2.3.538) and the K2 camera 
was operated using Gatan DigitalMicrograph software (ver.3.21.1374.0).    
 
2.10 Data processing    











The Gram-positive Tat differs from that of Gram-negative translocase due to the lack of 
TatB, itÕs a minimal system where TatA acts bi-functionally in a discrete TatAC complex 
(Barnett et al. 2008). Bacillus subtilis has three variants of the TatA protein, Ad, Ay and 
Ac, and two variants of the TatC protein, Cd and Cy. Two TatAC systems work in parallel, 
TatAdCd and TatAyCy, each with different substrate specificities. The only native 
substrate of TatAdCd is PhoD, a protein with phosphodiesterase and alkaline phosphatase 
activity which is only expressed during phosphate starvation conditions (Jongbloed et al. 
2000). To investigate the substrate selectivity of TatAdCd, the translocase was expressed in 
mutant ΔtatABCDE E. coli where partial complementation was evident (Barnett et al. 
2008). The discrete system expressed in tat null E. coli was also able to export the 
heterologous protein GFP with a TorA signal peptide (Albiniak et al. 2013). Moreover, 
during batch-fermentation, GFP protein showed export to the periplasm and release to the 
culture medium. In this study the TatAdCd translocase was expressed in tat null E. coli at 
shake-flask level to investigate which other proteins it could export to the periplasm. 
Initially partial complementation at shake-flask was checked with microscopy, then two 
native E. coli substrates were tested and finally a set of heterologous proteins (including a 
completely synthetic protein) were utilised. Some of the latter biotechnologically relevant 
molecules including hGH, IFN and an scFv had been tested with TatABC prior to this 
study. A completely synthetic protein, a maquette was also tested (G. Sutherland et al. 
2018). With a TorA signal peptide at the N-terminus and by expressing CyDisCo 
components, export to periplasm was evident in wild type E. coli cells (Alanen et al. 2014). 
The polycistronic expression of CyDisCo (Erv1p and hPDI) downstream of the POI allows 
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disulphide bond formation prior to Tat export (Hatahet et al. 2010; Nguyen et al. 2011) . 
The interesting export results using TatAdCd in tat null E. coli lead to the second 
investigation, the proofreading capability of the more discrete complex. 
  
The Tat system has long been known to reject (not export to periplasm), proteins that are 
not correctly or fully folded (Delisa et al. 2003)(Halbig, Wiegert, et al. 1999)(Richter & 
Brser 2005a). Proteins tested tended to be native Tat substrates such as FeS proteins fused 
to a TorA signal peptide (Matos et al. 2008a)(Delisa et al. 2003). A heterologous yeast 
nuclear pore protein Nsp1p was tested too, unfolded FG repeats were rejected to varying 
degrees raising the possibility hydrophobicity may cause Tat rejection (Richter et al. 2007). 
However, like tests in plant thylakoids, a correlation was seen between physical protein 
lengths, not just protein instability (Cline & McCaffery 2007).  Other unfolded 
heterologous proteins were tested to study TatÕs remarkable ability (Alanen et al. 2014) but 
the degree of mis-folding and/or gross unfolding made deducing what Tat ÔsensedÕ difficult 
to ascertain.  
 
An scFv (termed scFvM) was sourced, fused with a TorA signal peptide and histidine 
tagged to become an ideal tool to study wild-type TatABC proofreading (Austerberry et al. 
2017; Jones et al. 2016). See Figure 9. The collaborating group generated a number of 
variants, all classed as ÔfoldedÕ as determined by very similar Tm values, peak florescence 
and secondary structure values (via circular dichromism spectra), which were mutated 
originally for a solubility study. These mutants therefore were useful candidates to quantify 
TatÕs quality control based solely on conformation flexibility and surface features. 
Moreover scFvM has two disulphide bonds so CyDisCo could be used both to test TatÕs 
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structural flexibility acceptance (due to export efficiency of oxidized and reduced forms). 
The mutants were grouped into three main subsets: 
1) 1, 2 or 3 Lys-Glu salt bridges were introduced in place of un- charged residues,
increasing surface charge in a net-neutral manor (SB1, SB2, SB3). 
2) To create a more positively- or negatively- charged area, 5 uncharged surface residues
were substituted with Lys, Glu or Arg to create a 5Lys, 5Glu, and 5Arg. 
3) Hydrophobic domains were introduced to the N-terminal region via substitution of 4, 5
or 6 neutral, polar surface residues with Leu (4N-Leu, 5N-Leu and 6N-Leu). 
The somewhat surprising result was that TatABC could export the all of these mutants to 
the periplasm (export was only greatly reduced in the 5Arg mutant) suggesting that the 
Gram-negative system does tolerate major changes in surface charge and hydrophobicity 
(Jones et al. 2016). scFvM export was however highly dependent on CyDisCo expression, 
without it, only 10% of protein was exported in wild type cells. This dependency proposes
the theory TatABC can sense conformational flexibility. Another mutant  (scFvM 26tail) 
with an unstructured tail at the C-terminus blocks export confirming that unfolded regions 
are not tolerated. In this study the same scFvM mutants were tested for export using the 
Gram- positive translocase in tat null E. coli, with the aim of testing TatAdCdÕs 





Figure 9. scFvM wild-type modeled from two projections. 
The ribbon model shows β-sheets in green, α-helices in gold and loop regions in 
grey. 2 disulphide bridges on the top panel are circled red. Uncharged protein/neutral 
amino acids are coloured grey, while blue indicates positive and red indicates negative 
amino acids. The uncharged patch circled green is where salt bridge or charge 
substitutions took place. Finally, hydrophobicity is coloured yellow and hydrophilic 
areas are coloured purple. Images were made using CCP4 Molecular Graphics and 








3.2.1 Partial complementation of ΔtatABCDE by TatAdCd expression 
The E. coli Tat pathway is predicted to have relatively few substrates (Palmer et al. 2011) 
but mutant E. coli ΔtatABCDE (Δtat) cells exhibit a range of phenotypes, highlighting the 
importance of Tat. These defects include impaired septation, decreased motility and an 
increased sensitivity to detergent (Stanley et al. 2001). Failed full septation causes E. coli 
cells to divide improperly and hence, form chains up to 10 cells long that can be viewed 
under a light microscope (Harrison et al. 2005; Ize et al. 2003). A possible reason for this 
effect is the mislocalisation of cell wall amidases AmiA and AmiC, both Tat substrates 
(Bernhardt & De Boer 2003). Of importance to this study the filamentous phenotype is 
complemented by expression of TatABC machinery, but only partially complemented by 
expression of Gram-positive TatAdCd machinery in (Δtat) E. coli cells (Albiniak et al. 
2013). As B. subtilis Tat can export one of the most complex E. coli Tat substrates (TMAO 
reductase, TorA), it was assumed it would complement the mutant phenotype (Barnett et al. 
2008)(Mendel et al. 2008). However, the filamentous phenotype, at least during the 
fermentation process was still present when TatAdCd was expressed in Δtat E. coli cells, 
suggesting the complementation is not complete (Albiniak et al. 2013). In this study, we 
sought to visualise by light microscopy the phenotype of Δtat E. coli cells and the same 
cells expressing TatABC and TatAdCd from the pLys-BAD plasmid at shake flask, 2 and 5 
hours post induction- see Figure 10. The images show full complementation (single cell E. 
coli) when TatABC was expressed, but largely the characteristic ÔchainingÕ phenotype 





Figure 10. Light microscope images of Δtat cells expressing nothing, TatABC or 
TatAdCd 
Δtat cells were imaged either expressing nothing (top panels), TatABC (middle panels) or 
TatAdCd (bottom panels) from the pLysS-BAD plasmid after 2 or 5 hours of induction 
with arabinose (right and left images, respectively). The images show that TatABC 
complements the filamentous phenotype of Δtat cells, whereas TatAdCd does not. 
 
 
3.2.2 TatAdCd fails to export two native E. coli Tat substrates 
Before testing heterologous proteins we thought it important to check the ability of 
TatAdCd to export native E. coli Tat proteins. TatAdCd can export the E. coli Tat substrate 
TorA (Barnett et al. 2008)(Trimethylamine-N-oxide reductase) (Barnett et al. 2008), sized 
86 kDa with a molybdenum cofactor, but what about other native Tat proteins? The protein 
NrfC (25kDa) has a role in nitrate reduction and had been shown to be exported by Tat 








2 hours 5 hours 
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to the periplasm (P) where it is processed to the mature form, however TatAdCd rejects the 
protein and only the precursor form is present in the M (insoluble) fraction. FhuD (33 kDa), 
another native E. coli Tat substrate was synthesised for this study, is a periplasmic binding 
protein of ferric hydroxamate, an iron siderophore. Results (Fig. 11) show wild-type E. coli 
cells exporting FhuD to the periplasm (lane P), whilst TatAdCd did not export FhuD. The 





Figure 11. NrfC and FhuD native E. coli Tat substrates are not exported by TatAdCd 
The precursor forms of E. coli NrfC and FhuD were expressed in wild type (left panels) or 
Δtat cells expressing TatAdCd from the pLysS-BAD plasmid (right panels). After 3 hours 
induction, cells were fractionated into cytoplasm, membrane or periplasm samples (C, M, 
P). The samples were immunoblotted against the C-terminal His tag on the target 
substrates. Wild type cells were able to export protein to the periplasm, cleaved to mature 
size whilst TatAdCd expressing cells fails to export the proteins. 
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3.2.3 TatAdCd fails to export a range of proteins that are exported by TatABC  
The first heterologous protein tested in Δtat E. coli expressing TatAdCd was TorA-GFP, 
this protein was exported to the periplasm and then secreted to the medium during batch-
fermentation (Albiniak et al. 2013). In this study we investigated TatAdCd export with 
more complicated protein biotherapeutics during shake flask experiments. Proteins chosen, 
hGH, IFN α2β and a VH domain, had already been tested and successfully exported via 
TatABC with a TorA signal peptide. ItÕs interesting to note that although some of these 
proteins contain disulphide bonds, none required their formation prior to export by Tat. 
CyDisCo was therefore not required as the proteins formed near native structures without 
disulphide bond formation (Alanen et al. 2015). 
To test export, POIÕs were expressed from a pET-23 based plasmid alone in Δtat cells (the 
negative control) or co-expressed with either TatABC (the positive control) or TatAdCd 
expressed from a pLys-BAD plasmid. After 3 hours of expression, the cells were 
fractionated into cytoplasm, membrane and periplasm to identify the localisation of the POI 
within the cell via immunoblots against the C-terminal His6 tag. Expression and membrane 
positioning of TatABC and TatAdCd was confirmed with an immunoblot against the C-
terminal Strep II tag on TatC and TatCd- data not shown. 
TorA-hGH (23.6 kDa), TorA-IFN (20.7 kDa) and a TorA-VH domain construct (9.5 kDa), 
as expected, are exported to the periplasm in TatABC expressing cells as mature, processed 
protein (without TorA signal peptide). The unexpected result was that TatAdCd expressing 
cells failed to export any of these proteins, no mature protein was detected in the periplasm- 
see Figure 12. The cytoplasm and membrane fractions also lack much protein; they were 
probably subject to proteolysis when they did not export, as seen before (Alanen et al. 
2015). A media sample was also takenVKRZHGQRSURWHLQUHOHDVHGDWDQRWVKRZQ
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Figure 12. TatAdCd fails to export hGH, IFN and VH domain protein constructs 
TorA-hGH, TorA-IFN and TorA-VH domain constructs were expressed in Δtat cells and in 
Δtat cells expressing either TatABC or TatAdCd. After 3 hours induction, cells were 
fractionated into cytoplasm, membrane or periplasm samples (C, M, P). The samples were 
subjected to immunoblotting using antibodies to the C-terminal His tag on the target 
heterologous proteins. The negative control on the left, Δtat cells, do not export any protein 
to the periplasm. Δtat cells expressing TatABC exports all three proteins, which are cleaved 
to mature size in the periplasm. The test on the right, Δtat cells expressing TatAdCd fails to 
export the proteins to the periplasm. 
C M P C M P C M P





3.2.4 TatAdCd fails to export a Maquette protein 
While all the proteins tested previously are found in nature, the synthetically made 
Maquette protein is not. Based on the BT6 maquette developed (Farid et al. 2013), itÕs a 
small protein (17 kDa) consisting of four largely identical α-helices that form a water 
excluding cavity which accommodates cofactors. Its histidine residues within the cavity 
ligate two hemes, which make the tightly folded protein an ideal Tat substrate. Indeed 
TorA-BT6 is exported by TatABC and moreover, BT6 mutants that inhibit heme binding 
exhibit less tight folding which decreases TatÕs export ability further displaying TatÕs 
proofreading capability (G. Sutherland et al. 2018). Figure 13 shows Δtat TatABC 
expressing cells export TorA-BT6 maquette whereas TatAdCd expressing cells do not. 
Figure 13. The synthetically made Maquette protein is not exported by TatAdCd 
TorA-Maquette (21 kDa) is expressed in Δtat cells and in Δtat cells expressing either 
TatABC or TatAdCd. After 3 hours induction, cells were fractionated into cytoplasm, 
membrane or periplasm samples (C, M, P). The samples were subjected to immunoblotting 
using antibodies to the C-terminal His tag on the target heterologous proteins. Δtat cells do 
not export the maquette , itÕs degraded (17 kDa), TatABC expressing cells do, whilst 
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3.2.5 TatAdCd efficiently exports two different scFv proteins  
We next tested the export of two Tor-A scFv constructs through TatAdCd in Δtat cells. One 
scFv, scFvO was raised against the omega peptide of β-galactosidase, whilst the other, 
scFvM was raised against C-met. Both scFvÕs are translocated through wild-type TatABC. 
Of interest, svFvO does not require CyDisCo for export, whereas scFvM is much more 
dependent on the expression of CyDisCo for export (Jones et al. 2016)(Alanen et al. 2014). 
Figure 14 shows that both scFvÕs are exported by TatAdCd and moreover, similar to wild-
type Tat, scFvO export is independent of CyDisCo for export whereas scFvM is largely 
dependent on CyDisCo expression. This suggests that at least for scFvÕs, both translocases 




Figure 14. TatAdCd efficiently exports two scFvÕs, scFvM requires CyDisCo. 
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A. Two different scFvÕs termed scFvO and scFvM were expressed with an N-terminal
TorA signal peptide in Δtat cells and in Δtat cells expressing either TatABC or TatAdCd.
CyDisCo components Erv1p and PDI were also constitutively expressed with the proteins.
After 3 hours induction, the cells were fractionated to yield cytoplasm, membrane or
periplasm fractions (C, M, P) which were immunoblotted using antibodies to the C-
terminal His tag. The negative control Δtat cells do not export scFvÕs whilst both Δtat cells
expressing TatABC and Δtat cells expressing TatAdCd export scFvO and scFvM to the
periplasm, cleaved to mature size.
B. scFvM is only exported to the periplasm when CyDisCo is expressed.
3.2.6 Effects of scFvM surface mutations: TatAdCd is more selective than TatABC  
Up to this point, the only protein TatAdCd exported apart from GFP was scFvÕs. Therefore 
to investigate the proofreading capability of the Gram-positive Tat, structurally similar 
scFvM variants with surface mutations were tested via expression and export to the 
periplasm. These mutants had previously been tested with TatABC in E. coli and 
unexpectedly in general, the mutants had little effect on export efficiency compared to the 
unmodified scFv (Jones et al. 2016). Here, we tested whether TatAdCd was able to export 
the same range of variants, in order to test whether TatAdCd has different requirements to 
TatABC. Three mutants groups were generated in this study based on former literature of 
TatÕs proofreading, the salt-bridge group, the charged group and the hydrophobic group. To 
note, in some experiments (1SB and 5Glu) it appears the Δtat cells have not expressed the 
POI, however in our experience, these proteins have more than likely been degraded by 
proteases because they were not exported. 
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Figure 15A shows SB mutants (1 2 or 3 SBÕs), as shown previously TatABC exports these 
well but only 1SB and 2SB are exported reasonably via TatAdCd, 3SB is not exported at 
all.  
Figure 15B shows the charged group, which contain a more positively or more negatively 
charged areas (5 Lys, 5Glu or 5Arg). TatABC exports all the mutants, although the 5Glu 
variant is exported more efficiently than the 5Lys or 5Arg. Indeed in wild type cells, the 
5Arg mutant did greatly decrease the export efficiency with wild-type TatABC (Jones et al. 
2016). TatAdCd did export 5Glu and 5Arg, although not as efficiently as TatABC, but 
5Lys was rejected. Given this result, to seek whether TatAdCd inherently discriminated 
against Lys residues, a mutant was constructed where 5Arg residues were mutated to 5Lys 
residues (5R>K).  The results show TatABC exports 5Arg>K well and TatAdCd exports it 
lesser amount, but any export indicates TatAdCd does not have an inherent aversion to Lys 
residues. 
Finally in Figure 15C, the hydrophobic group with an N-terminal hydrophobic patch of Leu 
residues were tested (4N-Leu, 5N-Leu, 6N-Leu). Once again, TatABC exported all three 
mutants well but TatAdCd only exported the 4N-Leu mutant weakly. Both the 5N-Leu and 
the 6N-Leu variants were rejected for export via TatAdCd. Overall, this data suggests the 
Gram- positive Tat exhibits a far more stringent level of substrate specificity compared to 
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Figure 15. Differential export of mutant scFvM variants by TatABC and TatAdCd 
A. scFvM salt bridge variants SB1, SB2 and SB3 were expressed in Δtat cells and in Δtat
cells expressing either TatABC or TatAdCd with CyDisCo. After 3 hours induction, the
cells were fractionated to yield cytoplasm, membrane or periplasm fractions (C, M, P)
which were immunoblotted using antibodies to the C-terminal His tag. All salt bridge
variants were exported via TatABC whilst TatAdCd exported SB1 and SB2 to a lesser
extent but did not export SB3 to the periplasm.
B. scFvM variants with either significant positive (Lys or Arg) or negative (Glu) charge in
the same area were expressed in Δtat cells and in Δtat cells expressing either TatABC or
TatAdCd with CyDisCo. After 3 hours induction, the cells were fractionated to yield
cytoplasm, membrane or periplasm fractions (C, M, P) which were immunoblotted using
antibodies to the C-terminal His tag. All variants were exported via TatABC whilst
TatAdCd exported 5-Glu and 5-Arg to a lesser extent but did not export 5-Lys to the
periplasm. TatAdCd could however weakly export scFvM 5R>K mutant.
C. scFvM variants with increased surface hydrophobicity 4N-Leu, 5N-Leu and 6N-Leu
were expressed in Δtat cells and in Δtat cells expressing either TatABC or TatAdCd with
CyDisCo. After 3 hours induction, the cells were fractionated to yield cytoplasm,
membrane or periplasm fractions (C, M, P) which were immunoblotted using antibodies to
the C-terminal His tag. All variants were exported via TatABC whilst TatAdCd exported
only weakly exported the 4N-Leu mutant.
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3.2.7 TatAdCd rejects misfolded variants of scFvM  
Whilst the mutants point to a different level of substrate specificity, they do not address the 
question of whether TatAdCd rejects misfolded substrates. We therefore tested whether 
TatAdCd could export scFvM-26tail. This mutant has 26 residues appended to the C-
terminus of scFvM which causes it to be rejected by TatABC (Jones et al. 2016). TatAdCd 
also rejected the same construct (Fig.16). Another mutant scFvM-P172S has a substitution 
between the two major scFvM domains, which we suspect causes destabilization to its 
overall structure. TatABC exported this variant (Jones et al. 2016), whereas TatAdCd 
rejected svFvM-P127S. This result suggests TatAdCd does have the ability to proofread 
misfolded proteins and is more sensitive to substrate conformation than TatABC. 
 
 
Figure 16. TatAdCd rejects scFvM variants that are misfolded. 
TorA-scFvM variants P172S and 26tail (containing a 26- residue C-terminal extension) 
were expressed in TatAdCd-expressing CyDisCo cells, and the P172S mutant was also 
expressed in TatABC-expressing CyDisCo cells (top right). Samples were fractionated into 
cytoplasm, membrane or periplasm fractions (C, M, P) and immunoblotted using antibodies 
to the C-terminal His tag. TatABC can export the P172S mutant whilst TatAdCd rejects 
export along with the 26tail mutant. 
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The primary aim of this study was to further investigate the capabilities of the B. subtilis 
TatAdCd, to compare substrate specificity and proofreading abilities with its E. coli 
TatABC counterpart. The TatAdCd system has been less well studied, perhaps because it 
only has one native substrate, PhoD (a 64 kDa phosphodieasterase). Under phosphate 
limited conditions, TatAdCd is co-regulated from the phoD operon (Pop et al. 2002). A 
second Gram-positive minimal Tat system exists, TatAyCy. It too has a single substrate 
YwbN (a 46 kDa heme containing peroxidase) although is constitutively expressed 
(Jongbloed et al. 2004). Both systems are able to partially complement ΔtatABCDE E. coli 
cells by forming an active translocon, but only TatAdCd exported one of the largest known 
Tat substrates, TorA (90 kDa) (Barnett et al. 2008). Moreover, TatAdCd was shown to have 
a more relaxed specifity, not only could TatAd functionally replace TatAy (TatAy cannot 
replace TatAd), but when overexpressed, TatAdCd can aid the translocation of YwbN 
(Eijlander, Jongbloed, et al. 2009). Thus Jongloed et al, concluded thefore that TatAdCd 
could be a good candidate for comercial production of heterologous proteins. To test this, 
the model protein GFP was chosen and fused to the TorA signal peptide, TorA-GFP was 
able to be exported via TatAdCd in tat null cells, of E. coli as well as DmsA-YFP (Mendel 
et al. 2008). Further studies upscaling the process from shake flask to Batch fermentation 
studies were undertaken with overexpression of both TorA-GFP and TatAdCd in tat null 
cells. During the fermenation mature GFP was excreted into the culture medium from the 
periplasm (Albiniak et al. 2013). This study and Fig.10 perhaps provide some insight into 
why this happens. TatAdCd does not fully complement tat null cells, the filamentous 
phenotype of ΔtatABCDE E. coli cells is still visible upom Gram-positive Tat expression. 
Cell wall amidases (AmiA/AmiC Tat substrates) involved in cytokinesis are thought to be 
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mislocalised due to the absence of TatABC, perhaps TatAdCd can not export one or both 
proteins, leading to a defective cell envelope (Ize et al. 2003). Although itÕs interesting that 
TatAdCd can export GFP fused to an AmiC signal peptide (Barnett et al. 2009). But the 
primary failure of TatAdCd to export the enzymes (one or both) that cleave the division 
septum, could render the outer membrane compromised and hence ÒleakyÓ once the 
periplasm is full of heterologous protein. Such a platform has the potential for 
biotechnological exploitation as the system could decrease downstream purification and 
shield the protein from proteases within the cell. 
The native TatABC substrates NrfC and FhuD did not export via overexpressed TatAdCd 
in tat null cells, this result was not suprising as another native substrate, SufI (50 kDa), was 
also rejected by both TatAdCd and TatAyCy (Barnett et al. 2009). ItÕs unclear whether itÕs 
the proteins native signal peptide which is not recognised by TatAdCd (although they all 
contain the RR motif) or the mature protein which is not accepted for export.  
This study built upon previous studies with TorA signal peptide fused to alternative 
biotechnologically relevant heterologous proteins to exploring the substrate specifity of 
TatAdCd. When compared to the native E. coli Tat substrate data, overexpressed TatAdCd 
did not export a range of proteins which TatABC could. The proteins rejected for export 
through TatAdCd include a VH domain, IFN, hGH and a synthetically constructed 
maquette. ItÕs unclear why the Gram- positive Tat is unable to export these proteins, 
especially when these proteins are all smaller than other proteins it can export, GFP, PhoD 
and TorA. 
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However, TatAdCd was able to export two different scFvÕs, scFvO (CyDisCo independent) 
and scFvM (CyDisCo dependent). Dependency upon CyDisCo emulates the TatABC 
export system (Alanen et al. 2015)(Jones et al. 2016) and interestingly, scFvM is folded and 
active in the cytoplasm in a reduced state (Edwardraja et al. 2010). We interpret this to 
mean CyDisCo ÔlocksÕ the two scFv domains in a more rigid confirmation and is therefore 
deemed more sufficiency folded for Tat export. Perhaps this tight conformation is exactly 
what TatAdCd will export, the fact it rejected the svFvM-P127S mutant is evidence for
this. ItÕs known GFP folds extremely fast and tightly in the cytoplasm (and hence it cannot 
be exported by Sec) and speculatively, scFv might too have a tighter confirmation than the 
other heterologous proteins tested in this study. scFvMÕs CyDisCo dependance might also 
be because reduced cysteine residues are more hydrophobic than their disulphide bonded 
counterparts (Nagano et al. 1999) and the hydrophobic scFvM mutants were either rejected 
or significantly reduced in export via TatAdCd. 
Previously scFvM had been used to research the ÔproofreadingÕ phenomenon of TatABC 
(Jones et al. 2016) scFvM variants with surface mutations that are nonetheless structurally 
identical, were used to investigate TatÕs ability to sense surface charge (Edwardraja et al. 
2010). TatABC was able to export all the variants (although a couple to a lesser degree), 
however this study shows TatAdCd is much more selective. The presence of 1or 2 salt-
bridges (SB) is tolerated by TatAdCd, but 3SB is completely rejected; it is however unclear 
if this is due to the position of the third SB or because of structural changes. The second 
group introduced significant either positive (Lys or Arg) or negative (Glu) charge in the 
same area. TatAdCd exported mutantsÕ 5Lys and 5Glu, but 5Lys is completely rejected. 
Following this, 5Arg residues were mutated to 5Lys residues (5R>K) but TatAdCd weakly 
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exports this mutant, indicating TatAdCd does not have an inherent aversion to Lys residues. 
Further tests would be required to draw any conclusions regarding TatAdCdÕs preferences 
for substrate surface charge.  
A clearer picture is drawn when analysing the export efficiency of variants of increasing 
hydrophobicity in their N-terminal domain with TatAdCd. Exposure of hydrophobicity is a 
hallmark of unfolded or incorrectly folded protein and it has been shown previously 
exposed hydrophobic domains block export for small, unstructured proteins (Richter et al. 
2007). Although TatABC exported the hydrophobic scFvM variants, TatAdCd only 
exported 4N-Leu weakly and rejected 5N-Leu and 6N-Leu for export. This implies the 
TatAdCd proofreading mechanism rejects substrates above a certain hydrophobicity 
threshold, with the corresponding threshold for TatABC perhaps being set at a significantly 
higher level. 
Whilst the misfolded scFv-26tail mutant is rejected for export by both TatABC and 
TatAdCd as one would expect given previous misfolded studies (Delisa et al. 2003) 
(Richter & Brser 2005). The scFvM-P127S mutant that we suspect causes destabilization
to its overall structure (due to its location between the two major scFv domains) is exported 
by TatABC and not by TatAdCd. This strongly suggests TatAdCd is more sensitive than 
TatABC in responding to changes in substrate confirmation and/or its flexibility. 
Further investigations are clearly needed before a more definitive conclusion is made 
although itÕs evident TatABC and TatAdCd have different substrate selectivity 
mechanisms. Substrate hydrophobicity distinctly inhibited scFv mutant export via 
TatAdCd; alternative proteins (such as GFP) with hydrophobic patches could be 
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interesting. It would be interesting (although beyond the scope of this study) to more 
accurately identify both the heterologous proteins and the scFv variants structural 
flexibility. For example NMR would be a useful tool to link translocation efficiency and 
conformational flexibility. Finally TatAdCd is able to export a few proteins, there must be 
more it can translocate and will these proteins also be secreted to the culture medium 
during batch fermentation? 
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Biopharmaceuticals are largely therapeutic recombinant proteins produced from biological 
sources obtained by a biotechnological process. The production of the first therapeutic 
protein in the early 1980Õs generated a new industry, which has since thrived. 50% of the 
Òbest selling drugsÓ are currently biopharmaceuticals (Jozala et al. 2016) and the trend is 
still increasing as advances in science continue. Bacterial hosts were initially used and 
although other systems exist (mammalian, yeast, insect), bacterial hosts still account for 
30% of recombinant pharmaceuticals on the market (Overton 2014) due to their rapid 
growth, high yield, cost-effectiveness and ease of scale up.  
Monoclonal antibodies account for approximately half of the total sales of 
biopharmaceuticals (Ecker et al. 2015), however bacteria cannot fulfill eukaryotic post-
translational modifications so are used for production of small antibody fragments instead. 
The antibody single-chain variable fragment (scFv) and antigen-binding fragment (Fab) 
became the most popular forms as the derivatives are easily manipulated and produced, but 
most importantly have specific antigen selectivity (Gupta & Shukla 2017). Indeed, scFv 
specificity, affinity and efficacy are integral and once designed they can be utilised for the 
preparation of immunotoxins, therapeutic gene delivery or as anti-cancer intrabodies 
(Ahmad et al. 2012).  
Antibody formats are shown in Figure 15. A complete antibody contains four polypeptides, 
two identical heavy chains and two identical light chains connected by disulphide bonds 
and decorated with glycans. A Fab contains a variable and constant region from each chain 
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too, but only those that associate with the antigen. Whereas an scFv is simply composed of 
a variable heavy (VH) and a variable light (VL) region, joined by an additional flexible 
linker. A diabody exists as a non-covalent dimer of scFv, this structure has the capacity of 
multivalent binding, hence, there is an opportunity to design multifunctional antibody 
reagents. 
Figure 17. Antibody formats. 
A whole antibody (IgG) has two identical light (L) chains and two identical heavy chains 
(H) bound by covalent and non-covalent forces. Each light chain is bound to a heavy chain
by a disulphide bonds and the heavy chains are too linked by disulphide bonds (red lines).
An antibody also contains complex carbohydrate structures (not shown). The upper variable
regions (V) are responsible for specific antigen binding, whereas the lower constant regions
(C) mediate biological activity. A Fab fragment contains two variable regions and one
chain each from the constant region. Whilst an scFv only has two variable regions, usually
linked by an additional linker (blue line) of at least 15 residues. A diabody has a much
smaller linker (<11 residues), the protein cannot fold but non-covalent interactions can
form a dimer structure.
Although many scFvÕs (just like in this study) originate from a phage display screen, their 
overall design is important for expression, stability and function. scFv construction should 
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specific as to which order expresses and thereafter ÔworksÕ best (Vlkel et al. 
2001)(Weatherill et al. 2012).   
Linker addition helps inherent instability issues (Bird et al. 1988) and its length is very 
important, the linker must span 3.5 nm between the C- terminus of the variable domain and 
the N-terminus of the other domain without affecting the ability of the domains to fold and 
form the binding site (Wrn & Plckthun 2001). A short linker (3-11 residues) is unable to 
fold into a functional Fv domain, but can form non-covalent dimers with other scFvÕs to 
form a diabody. The average linker is 15-20 residues which contain hydrophilic amino 
acids to avoid intercalation, often stretches of Gly and Ser are used for flexibility, 
(GGGGS)4 is often used for example (Ahmad et al. 2012).  
Finally, the stability of the scFv is imperative; it must at least be able to withstand 
physiological temperatures and pH. VH and VL association can be increased by the addition 
of intermolecular disulphide bonds. Disulphide stabilisation in one study showed 
pronounced improvement (>60 fold) of an scFvÕs half-life at 37oC (Glockshuber et al. 
1990). Another more recent study tested six disulphide bond locations and identified the 
best position (in terms of its biophysical properties). VH40-VL100 was then tested in 6 
different scFvÕs to identify an interchain disulphide bond position that might improve the 
biophysical characteristic of scFvÕs universally (Weatherill et al. 2012). Although the 
disulphide stabilisation did not confer global protein stability (increased Tm for example), 






001 VH- linker-VL 
002 VH- linker- VL X 
003 VH-short linker-VL 
004 VH-short linker-VL X 
005 VL-linker-VH 
006 VL-linker-VH X 
007 VL-short linker-VH 
008 VL- short linker-VH X 
Table 9. CEA6 scFv construct designs. 
8 scFv constructs were chosen for this study; 001-004 have VH-VL orientations, while 005-
008 have VL-VH orientations. 003/004/007/008 have a short linker and all even number 
constructs have an additional disulphide bond and are therefore Òdisulphide stabilisedÓ. 
This study sought to test the ability of Tat to export 8 different variants of a widely used 
biopharmaceutical scFv specific for human carcinoembryonic antigen (CEA), commonly
present on colon/rectal cancer cells (Osbourn et al. 1996). The scFvÕs were designed to be 
either in a VH-VL or VL-VH orientation, half were disulphide stabilised (with an additional 
disulphide, to have 3 disulphide bonds in total) and the variants had both long (GGGGS)4 and 
short (GGGGS)1 linkers. See Table 9. These designs were created to ascertain which variants 
expressed, folded and exported the best via Tat at shake flask and fermentation 
experiments. Information from our collaborators at MedImmune indicated that these 'new-
format' scFv variants are difficult to express by traditional routes (cytoplasmic expression 
or export via Sec). 
Each construct had a Tat specific TorA signal peptide and a C-terminal histidine tag for 
detection. For best results, the constructs were expressed (unless stated otherwise) in BL21 
TatExpress cells, which have an engineered strong inducible bacterial promoter, ptac, 
upstream of the chromosomal tatABCD operon so that the Tat system is overexpressed 
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when IPTG is added. hGH export with a TorA signal peptide was increased 5 fold using 
TatExpress cells in comparison to wild-type (Browning et al. 2017). CyDisCo (hPDI and 
Erv1p) was also tested to aid disulphide bond formation in the scFv in the cytoplasm 
(Gaciarz et al. 2017). Optimisation of growth media was also undertaken, not least because 
medium composition can affect relative levels of soluble recombinant protein (Broedel et 
al. 2001).  
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4.2 Results 
4.2.1 VH-VL format CEA6 scFvÕs express best in LB 
All eight new format antibody structures (derived from CEA6) were expressed from a pET 
plasmid with an N-terminal TorA signal peptide for export to the periplasm and a C-
terminal histidine tag for detection. The experiments used BL21 TatExpress cells which 
increase the number of Tat complexes in the membrane for best export yields (Browning et 
al. 2017). Previously two different scFvÕs have been exported via E. coli and B. subtilis Tat, 
one was CyDisCo dependent (scFvM) (Jones et al. 2016) and the other was not (Alanen et 
al., 2014). Therefore all constructs were co-expressed with CyDisCo on a different pBAD 
plasmid. The constructs were initially tested in LB media (like all other biotherapeutics 
tested in Chapter 3) and after 3 hours of expression, the cells were fractionated into 
cytoplasm, membrane and periplasm to identify where the variant scFvÕs had localised in 
the cells. 
Only three of the eight formats were detectable when expressed in LB; 001, 31.5 kDa (VH-
VL), 002, 31.5 kDa (VH-VL disulphide stabilised) and 003, 30.5 kDa (VH-VL short linker). 
However, they did not export and were mostly localised in the M, insoluble membrane 
fraction, Figure 18. This figure demonstrates the VH-VL orientation is best for protein 
expression in this system and that non-disulphide stabilised, long linker expresses the best 
according to band densitometry.  
91 
Eight new format TorA-scFv constructs were tested in BL21 TatExpress cells, with 
CyDisCo, grown in LB media. After 3 hours induction, cells were fractionated into 
cytoplasmic, membrane or periplasm fractions (C, M ,P) and immunoblotted using 
antibodies to the C-terminal His tag. Only three constructs expressed and were localised to 
the M fraction, so were not exported by Tat. These expressed proteins were all in a VH-VL 
format; 001 expressed best with a long linker and only 2 disulphide bonds whereas 002 and 
003 expressed less well, with an additional disulphide bond and a short linker, respectively.  
4.2.2 LB and TB media experiments give similar results 
The experiment (Section 4.2.1) was repeated in TB media to increase cell density. Teriffic 
Broth can also increase protein yields per cell and thus we hoped this would encourage 
translocation (Choi & Geletu 2018) of the scFvÕs to the periplasm. However, Figure 19 
shows the expression levels and location of the three expressing scFvÕs are similar to the 
LB experiment, although the disulphide stabilised construct is now expressed less than the 
























New format TorA-scFv constructs were tested in BL21 TatExpress cells, with CyDisCo, 
grown in TB media. After 3 hours induction, cells were fractionated into cytoplasmic, 
membrane or periplasm fractions (C, M ,P) and immunoblotted using antibodies to the C-
terminal His tag. Identical to expressions in LB media (Figure 18), the same three 
constructs expressed and were localised to the M fraction. However, the expression of the 
short linker variant (003) is better in TB than LB.  
4.2.3 Auto Induction Media enables the export of 001/2/3 CEA6 scFv constructs 
Auto Induction Media (AIM) was also tested with all 8 constructs. AIM was particularly 
suited this system as it is formulated to auto induce IPTG inducible (T7 promoters), and all 
constructs and TatExpress are under this promoter. Moreover, the media was developed for 
BL21 strains, so the TatExpress BL21 cells were optimal. The cells were pre-cultured in 
LB overnight and transferred to AIM for cell expression. At OD 0.4 the cells were induced 
with arabinose for pBAD CyDisCo production, but were not induced with IPTG. After both 
3 and 21 hours (the latter time point was proven best for AIM expressions) (Studier 2005) 
the cells were fractionated. Figure 20A shows that after 3 hours, 001, 002 and 003 
constructs were leaking into the periplasm. TorA was not cleaved from the scFv therefore 




















recovered as only TorA cleaved (mature) 001, 002 and 003 proteins were identified in the 
periplasmic fraction. Again, expression of disulphide stabilised 002 scFv construct is less 
than the non disulphide stabilised  
Eight new format TorA-scFv constructs were tested in BL21 TatExpress cells, with 
CyDisCo, grown in Auto Induction Media (AIM). Neither TatExpress nor scFv constructs 
were directly induced with addition of IPTG, but at OD 0.4 CyDisCo was  
induced with arabinose. A. After 3 hours of induction, cells were fractionated into 
cytoplasm, membrane and periplasm. Protein was mostly localised in the M fraction, but 
small amounts of precursor were visible in C and P too. B. After 21 hours of nduction cells 




































protein is present but mature scFv has been exported to the periplasm. Best export is 
prevalent for the 001 construct, then 003 and finally the disulphide stabilised construct is 
less well expressed and exported.  
4.2.4 Auto Induction Media hGH controls using TatExpress 
As AIM had never been tested in our laboratory and the results were somewhat surprising, 
we used AIM with hGH control proteins to investigate the apparent lysing at 3 hours and 
export at 21 hours. Mature (without a signal peptide) and pre-protein (with a Tat specific 
TorA signal peptide) hGH were expressed in AIM using TatExpress cells. Without a signal 
peptide hGH will not export through Tat and will remain in the cytoplasmic fraction, but 
with TorA signal peptide, hGH can export through Tat to the periplasm.  
The control results emulated the findings obtained in Section 4.2.3. After 3 hours and 21 
hours Ôpost inductionÕ (after OD 0.4 was reached), the cells were fractionated into 
cytoplasm, membrane and periplasm. The results show in Figure 21 that after 3 hours 
induction, both the mature and TorA- hGH proteins are present in the periplasm (at 22 
kDa). It is likely that the mature hGH is present in the P fraction due to lysis of some of the 
cells. After 21 hours post induction, although the TorA-hGH construct has accumulated 
more as mature hGH in the periplasm, the second construct (mature hGH) is no longer 
present in the periplasm, suggesting that the cells are more intact at this point. 
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Figure 21. Auto Induction Media TorA- and mature hGH controls. 
TorA- and mature hGH were expressed in BL21 TatExpress cells using Auto Induction 
Media (AIM). After 3 and 21 hours of induction, the cells were fractionated into cytoplasm, 
membrane and periplasm and immunoblotted using antibodies to the C-terminal His tag. 3 
hours post induction, both the TorA- and mature hGH are in all three fractions, although 
TorA-hGH also has the precursor protein in the M fraction. However after 21 hours 
induction, although more hGH is present in the TorA-hGH periplasm, no mature hGH is 






















4.2.5 CyDisCo increases expression and export of CEA6 constructs 
To investigate whether the proteins were dependent on the cytoplasmic expression of 
CyDisCo, the second plasmid (pBAD) CyDisCo was not co-transformed alongside the 8 
constructs in TatExpress. The test proteins were instead solely expressed in AIM and the 
cells were fractionated at 3 and 21 hours post induction. There was no difference in cell 
growth without CyDisCo but protein expression and thereafter export differed significantly. 
Figure 20 shows two overexposed western blots, the blots had to be overexposed to identify 
protein presence. This alone indicates low protein expression or perhaps the protein was 
expressed as normal, but was degraded faster due to improper folding. After 3 hours post 
induction, 001, 002 and 003 are expressed in the cytoplasm/membrane fractions; no scFv is 
present in the periplasm. After 21 hours expression, 001 was exported (but to a lesser 
amount than with CyDisCo), 002 and 003 are not exported to the periplasm. Therefore, 






























Figure 22. Without CyDisCo, CEA6 scFvÕs express and export less well. 
Eight new format TorA-scFv constructs were tested in BL21 TatExpress cells, without 
CyDisCo, grown in Auto Induction Media (AIM). After 3 and 21 hours of induction, 
the cells were fractionated into cytoplasm, membrane and periplasm and 
immunoblotted using antibodies to the C-terminal His tag. A. 3 hours post induction 
without CyDisCo, the protein expression levels were much lower, protein is present in 
the cytoplasm and membrane fraction. B. 21 hours post induction without CyDisCo, 
protein expression levels are still very low and only 001 construct is exported (to a 







4.2.6 TatAdCd fails to export the CEA6 scFv constructs without CyDisCo 
TatAdCd was previously able to export two different scFvÕs, Section 3.2.3 (Frain et al., 
2017). To test whether it would also export other scFvÕs, delta tat cells were transformed 
with pBAD TatAdCd and the 8 scFv variants. As TatAdCd was expressed from a pBAD 
plasmid, pBAD CyDisCo could not be expressed, so these experiments were undertaken 
without the presence of CyDisCo. At 0D 0.4, tatAdCd was induced with arabinose while 
the constructs were left to auto-induce in AIM. 21 hours post induction, delta tat cells were 
fractionated into cytoplasm, membrane and periplasm. Although all 8 scFv variants did not 
export by TatAdCd, this was expected as no CyDisCo was expressed and Section 4.2.5 
demonstrated the importance of CyDisCo. However, the unexpected result was that (for the 
first time) more than three constructs expressed, see Figure 23. As usual, 001 and 003 were 
detected in the M/insoluble fraction, while 002 (DS) was hardly detectable.  004, 006, 007 
and 008 CEA scFv were also visualised in the M/insoluble fraction. After this result, 
CyDisCo was cloned polycistronically behind each scFv to test the ability of TatAdCd to 
export these proteins with CyDisCo and to streamline the auto-induction process.  
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Figure 23. New format scFvÕs are expressed in delta tat, AdCd expressing cells in AIM 
 TorA-scFv constructs were tested in delta tat cells expressing TatAdCd without CyDisCo, grown in 
Auto Induction Media (AIM). After 21 hours induction, the cells were fractionated into cytoplasm, 
membrane and periplasm and immunoblotted using antibodies to the C-terminal His tag. Almost all 
constructs expressed protein (to varying degrees) and protein was mostly localised in the M 







A. Precursor scFv 001 expressed best, whereas 002 is weakly expressed and 003 localises
in the membrane fraction as precursor and mature scFv.
B. 004, disulphide stabilised short linker scFv is just identifiable in the cytoplasmic
fraction, 005 VH-VL is not expressed but its disulphide stabilised partner 006 is expressed
and found in the M fraction.
C. Both VH-VL orientations with short linkers are expressed, but the non-disulphide
stabilised variant expresses slightly better, albeit theyÕre both localised in the M fraction.
4.2.7. Expression of scFv formats is not successful in SM6 media at shake flask  
Three proteins in the VH-VL domain orientation were exported to the periplasm when 
grown in AIM with CyDisCo, Section 4.2.3. In two more standard media we did not 
observe scFv export (Section 4.2.1 and 4.2.2), but it was important to test the fermentation 
media, SM6, at shake flask too. Unlike other media, a pre-inoculant is grown for 6 hours in 
PY media before 1 mL is transferred to SM6 media. In SM6 at 0D 2, cells are induced with 
IPTG for 24 hours and then fractionated into cytoplasm, membrane and periplasm. Figure 
22 shows both protein expression and export using SM6 was largely unsuccessful. Protein 
variants 001, 002 and 003 (with CyDisCo cloned on the same plasmid) were not expressed 
well, hence the oversaturated blot and all protein was localised in the membrane/insoluble 
fraction.   
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4.2.8 Fed-batch fermentation of scFv constructs is successful but scFvÕs are not 
exported 
Although at shake flask, SM6 media did not express or export the scFv constructs well, we 
thought the different conditions during fed-batch fermentation might be more beneficial. 
The three most successful constructs with CyDisCo were tested in parallel in Minifors 2 
using eve¨ software.  Figure 25A shows the OD 600 growth curve of all 3 constructs from 
when culture temperature was dropped to 25oC at 17 hours culture time to 60 hours culture 
time. Constructs 001 and 002 grew best and reached ODÕs of 120 and 115, respectively. 
003 scFv did not grow as well as it only reached OD40 but all three constructs were 
induced at the same time point with IPTG. The cells were fractionated into cytoplasm, 













Figure 24.VH-VL format scFvÕs are expressed in TatExpress cells using SM6 media 
Eight new format TorA-scFv constructs were tested in BL21 TatExpress cells, with 
polycistronically expressed CyDisCo, grown in SM6 media. After 21 hours induction, 
cells were fractionated into cytoplasmic, membrane or periplasm fractions (C, M ,P) and 
immunoblotted using antibodies to the C-terminal His tag. 001, 002 and 003 constructs 
expressed poorly and were localised to the M fraction, so were not exported by Tat.  
- TorA scFv
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membrane and periplasm pre-induction and 3, 20 and 29 hours post-induction. Pre-
induction the blots were both blank (not shown). Figure 25B shows anti-his blots for 3 and 
20 hours post scFv induction. At 3 hours, 001 and 002 are expressed but localised in the M 
insoluble fraction, 003 is not seen. Whereas 20 hours post induction, 002 is now mostly 
degraded and 003 is expressing in the M insoluble fraction. The general protein amounts 
are however very low. Figure 25C shows anti-flag blots for PDI on CyDisCo (57 kDa), 
CyDisCo is expressed well in the cytoplasm of both 001 and 002 constructs, but not so well 
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The three most promising scFv variants were tested with CyDisCo in fed batch 
fermentation using SM6 media. Cells were collected and fractionated pre-induction and 3, 
20 and 29 hours post-induction with IPTG. Cytoplasm, membrane and periplasm fractions 
(C, M ,P) were immunoblotted using antibodies to the C-terminal His tag and the N-
terminal PDI CyDisCo flag tag. 
A. Cell growth was measured by taking OD600 every hour from 17 to 60 hours culture
time during the day. Constructs 001 and 002 grew well and reached ODÕs of 120 and 115, 
respectively. 003 scFv did not grow as well as it only reached OD40. B. At 3 hours post 
induction, protein expression of constructs 002 and 003 were very low and protein was 
localised in the M fraction. 003 is not detected. Whereas at 20 hours post induction (lower 
panel) 002 is no longer detected, but 003 is now expressing localised to the M fraction. 
C. CyDisCo expression from 3 hours and 20 hours post induction is similar, PDI in
CyDisCo is mostly present in the cytoplasmic fraction. PDI (in CyDisCo) polycistronic 
expression in 003 construct is much weaker than the other two constructs. 
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Figure 25. Growth curves, scFv and CyDisCo blot of 001, 002 and 003 VH-VL  constructs 






The eight CEA scFv variants were created to test TatÕs ability to export different protein 
orientations, disulphide stabilisation states and novel bispecifics, diabodies. It was clear 
from the beginning using LB media, that the VH-VL orientation was favored as only these 
proteins expressed at all; an expression preference due to variable region order has been 
noted previously (Tsumoto et al. 1994), but is scFv dependent.  The fact that this 
orientation is preferred is not surprising as this scFv was selected in the VH-VL format from 
a phage screen (Osbourn et al. 1996); moreover, this orientation leaves the N-terminal end 
of the heavy chain variable region free, which contributes most to antigen interactions.  
All variants had an N-terminal, Tat specific TorA signal peptide for export to the periplasm. 
In several of the constructs tested previously, the TorA signal peptide includes four 
additional residues of mature TorA protein to ensure authentic and efficient Tat export 
(Fisher et al. 2008). However proteolytic cleavage after ATA (Figure 3) means the 
additional residues remain on the mature biotherapeutic protein, producing an unfinished 
product, which is not ideal. Therefore, these constructs were the first to be tested without 
the four residues, which might contribute to the initial lack of export. This hypothesis might 
be far stretched, but a very recent study demonstrates the importance of the early mature 
part of Tat precursor proteins in TatBC binding (Ulfig & Freudl 2018). It is also interesting 
to note that our group has identified an alternative signal peptide, PhoD, which particularly 
exports scFvÕs well (unpublished) but the signal peptide requires altering for Tat 
specificity. Perhaps this could be tested in the future.  
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Disulphide stabilisation within the construct was a key component of this investigation as 
some literature has shown that this is beneficial (Section 4.1). Disulphide-stabilised 
constructs have never before been used with the Tat system, but it was considerd likely that 
the more folded the protein, the less conformational flexibility it has and the more likely the 
Tat system would export the protein as fully folded. The requirement for CyDisCo (Section 
4.2.5) supports that disulphide bond formation is necessary for better scFv expression and 
export, which has been seen previously (Jones et al. 2016). However, the addition of one 
more disulphide bond to allow disulphide stabilisation did not aid expression or export, if 
anything CEA 002 expression was less than that of its non-disulphide stabilised partner. 
Although this might sound contradictory, additional disulphide bonds have been known to 
destabilise the protein in some cases (Pecher & Arnold 2009), and disulphide bond 
positioning is very important. It is also possible that the addition is unfavorable because the 
extra disulphide bond is another folding process for the protein. A Tat study, using an scFv 
protein suggests Tat export competence is related to the protein folding rate (Ribnicky et al, 
2007). In my study, the additional disulphide bond would have slowed down protein 
folding and perhaps therefore hampered export. 
A surprising result from this study was that scFv export was only ever seen when Auto 
Induction Media (AIM) was used, although we also tested three other media. AIM was a 
method first described by Studier, based on the different metabolic states on each individual 
cell, expression is induced automatically (Studier 2005). The method is not only very 
simple (no need to measure OD), but the system has been shown to increase protein yield 
and solubility (Grabski et al. 2005)(Lebendiker & Danieli 2014). Tat will not export 
aggregated, insoluble protein and so perhaps AIM offers just the right conditions for export. 
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I have not found in the literature an example of export incompetence being reversed using 
AIM, and this study is therefore novel.  
The ability of scFv 003 to form a diabody either in the cytoplasm (pre-transport) or in the 
periplasm could be tested by running a native gel. Diabody formation could account for the 
export results and could demonstrate a novel form of Tat-exported  recombinant protein. 
Other future perspectives include testing the ability of TatAdCd to export the scFvs with 
CyDisCo. One can hypothesise that they would export (like the other 2 scFvÕs) but these 
experiments were not carried out due to lack of time. Downstream, other approaches could 
also be investigated to aid Tat protein export in the future such as codon harmonisation 
(Claassens et al. 2017) and harmonisation of the target gene expression with Tat 
(Baumgarten et al., 2018).  
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The Gram- negative and Gram- positive Tat systems have clear functional overlap, but their 
differing sizes and compositions allude to alternative, interesting export mechanisms. The 
data presented in this thesis further highlight their distinctions as Gram- positive TatAdCd 
has greater substrate selectivity and a tighter proof reading mechanism than TatABC in E. 
coli (Frain et al. 2017). To investigate the structure of B. subtilis TatAyCy, a novel, 
detergent free Styrene Maleic Acid (SMA) approach was undertaken to study the 
translocase structure. 
Reminiscent of the situation in E. coli, TatAyCy is composed of two membrane protein 
complexes: TatAyCy and TatAy, which (as judged by gel filtration) form complexes of 
~200 kDa (Barnett et al. 2009). TatAdCd is similarly sized at ~230 kDa hence both 
minimal TatAC systems are significantly smaller than E. coli TatABC (Barnett et al. 2008) 
which exists in a complex of ~370 kDa (Oates et al. 2005).  
All Tat systems can export large substrates, which argues against the ÔsimpleÕ channel 
forming model (like the SEC pathway) as the diameters of Gram- positive discrete TatA 
complexes are too small to export these proteins. Instead a translocation mechanism which 
involves the coalescence of relatively homogenous TatA complexes, with the formation of 
a more flexible pore (whose diameter adjusts according substrate size) has been suggested 
(Beck et al. 2013) (Baglieri et al. 2012). But recent doubt has also been cast on this model 
in E. coli TatA due to the arrangement of its APH (Koch et al. 2012)(Rodriguez et al. 2013) 
and a lack of flexibility in its glycine hinge (Walther et al. 2010). In which case the 
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alternative export mechanism Òmembrane destabilisationÓ is favoured (Brser & Sanders 
2003) and too supported by E. coli TatA data (Hou et al. 2018). A lack of knowledge still 
surrounds the structural properties of TatAyCy and TatAdCd; better structural insight could 
assist in explaining the Gram-positive Tat mechanism.  
Published structural data largely focuses on E. coli individual constituents: TatA (Gohlke et 
al. 2005)(Zhang, Hu, et al. 2014), TatB (Zhang, Wang, et al. 2014), TatC (Ramasamy, 
Abrol, Suloway, Clemons, et al. 2013)(Rollauer et al. 2013) and TatE (Baglieri et al. 2012). 
However individual Gram- positive TatAd and TatCd structural data exists too (Walther et 
al. 2010)(Beck et al. 2013)(Nolandt et al. 2009).  But thereÕs a lack of structural 
information on entire Tat complexes because pursuit of 3D Tat reconstruction is limited by 
several factors. Firstly, the interaction of Tat and its substrates in the inner membrane is 
transient and therefore hard to capture. Its heterogeneity is also a problem, as thousands of 
particles would have to be gathered to obtain enough data to represent the entire size range 
of the complex. And finally, TatÕs relatively small size makes it difficult to obtain electron 
microscopy of sufficiently high contrast data for analysis. However, due to the particularly 
small sizes of TatAyCy and TatAdCd these complexes have the advantage of being small 
enough to fit into a SMALP. 
Membrane proteins ideally need to be kept in their native environment, the lipid bilayer, to 
maintain their structural integrity. The process of membrane protein purification therefore 
usually relies on detergent as their inherent amphipathic nature mimics the lipid bilayer. 
Regardless of the fact detergent screening can be time costing and expensive, the scientific 
basis behind the approach is too somewhat flawed. The detergent micelle created only 
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provides a rough approximation of the natural environment and can also lead to 
miscalculation of actual protein size. Moreover, recent studies have shown that the lipid 
bilayer does not simply act as a scaffold as it can too have profound effects on protein 
structures and/or function (Lundbaek et al. 2010). The novel approach of using Styrene 
Maleic Acid (SMA), which has alternating hydrophobic styrene and hydrophilic maleic 
acid moieties, allows membrane protein extraction by encapsulating the protein within its 
native lipid bilayer, see Figure 26 (Postis et al. 2015). This method results in maintenance 
of protein function and is highly amenable to single-particle cryo-EM (Gulati et al. 2014). 
Hence in this study, TatAyCy was purified with a SMALP scaffold and characterised using 




Figure 26. Two membrane protein stabilisation methods, detergent v SMA. 
Membrane protein is shown in blue. A. It is common for proteins to be solubilised 
with detergent (red) to create a spherical micelle. B. Using SMA, the native lipid 
bilayer is kept intact (yellow), amphipathic SMA copolymers form discoidal 
particles, nanodsics, which wrap around the protein complex and plasma membrane. 
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5.2 Results 
5.2.1 Affinity chromatography of TatAyCy 
Membranes containing TatAyCy were isolated as described in Materials and Methods and 
SMA was used to perturb the native membrane to create SMALPs. To achieve a highly 
pure sample, two purification steps were used. Initially affinity chromatography was 
performed using a nickel charged IMAC SepharoseTM column, which would specifically 
bind the 10X His tag on the C-terminus of TatCy. Unspecific proteins were either captured 
as flow through or washed off the column with an increasing imidazole gradient. Tightly 
bound proteins (His tagged) were eluted with a maximum 200mM Imidazole concentration. 
Each column step was analysed both by SDS-PAGE stained with Coomassie and blotting 
against the C-terminal His tag.  The results are shown in Figure 25. 
Figure 27A is the Coomassie stained SDS-PAGE gel. Lane 1 is post SMA addition to the 
membrane sample and lane 2 is column flow through, they both contain hundreds of 
proteins that need to be removed. Lanes 3 to 5 show an increase from 5mM to 60mM 
imidazole in the wash buffer. Each wash was 3 column volumes and with each increase in 
imidazole, the sample becomes purer. There is some TatAyCy in these samples, suggesting 
not all bound to the beads, but the majority of the protein was eluted. Lanes 6 to 10 are the 
elution fractions; the most prominent protein bands are TatAy (5 kDa) and TatCy (28 kDa) 
so the purification was successful and there was co-elution of the complex.  However other 
contaminating proteins are still present. 
Figure 27B shows the corresponding blot, His antibody was targeted to the C-terminal 10X 
his tag attached to the TatCy. Intense bands in lanes 5 to 10 validate the presence of TatCy 
at 28 kDa. Perhaps a small amount of protein degradation is also present at about 20 kDa 
but this is minor in comparison to the purified TatCy protein. 
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Figure 27. Purification of TatAyCy by Affinity Chromatography. 
E. coli membranes were isolated from Δtat cells expressing TatAyCy from a pBAD
plasmid and subjected to SMA. SMALPs were then applied to a nickel charged IMAC
SepharoseTM column for affinity chromatography via the 10X His tag on TatCy. A:SDS-
Polyacrylamide Coomassie stained gel visualised (in order) SMA addition to isolated
membranes, flow through, wash fractions and elutions in lanes 6 to 10. TatAy and TatCy
are highlighted on the right. B: The corresponding gel was immunoblotted using antibodies


























5.2.2 Gel filtration of TatAyCy complex 
The second polishing purification step involved using a Superdex200 10/300 gel filtration 
column on an KTAª FPLC system. Affinity purified TatAyCy, specifically fractions 7 
and 8 were pooled and subjected to size elution chromatography for further purification to 
obtain a homogeneous complex for Cryo EM analysis. 0.5mL was applied to the column 
and fractions were eluted in 0.5 mL. Peak fractions, 18 to 22, in the spectra observed when 
absorbance was measured at 280 nM (Figure 28) and fractions either side were analysed 
further.  
Figure 29A shows the SDS-PAGE stained Coomassie of the fractions; TatAyCy is now 
very pure with either a few or no contaminating proteins. Confirmation of TatAyCy 
purification is seen in Figure 29B, a blot against the N-terminal 10X his tag attached to the 
TatCy. The sensitivity of the blot in comparison to a Coomassie stain means TatCy is 
identified in more fractions than the Coomassie stain. It is also important to note that in 
comparison to affinity chromatography (Figure 27), the band is less intense perhaps 
signifying the protein is now less concentrated.  
Figure 28. Chromatogram of TatAyCy by Size Exclusion Chromatography.  
Affinity purified TatAyCy was applied to a Superdex200 10/300 gel filtration column and 





Figure 29. Purification of TatAyCy by Size Exclusion Chromatography. 
A. SDS-Polyacrylamide Coomassie stained gel visualised fractions 17 to 25 which showed
the complex to be co-eluted and very pure. B. The corresponding gel was immunoblotted
using antibodies to the C-terminal His tag on TatCy to confirm the proteins presence .

























5.2.3 Negative stain electron micrographs of TatAyCy 
Negative staining is a routine sample preparatory step to increase contrast under the 
electron microscope. The method is rapid and useful for the detection of small biological 
macromolecules, so the step is vital for the initial characterisation of Tat protein complexes. 
TatAyCy samples eluted from affinity and size exclusion chromatography were coated in a 
thin layer of dried heavy salt method (Section 2.8.1) before imaging at the University of 
Warwick by Dr Sarah Smith. The amount of protein purified was problematic at this stage, 
so I optimised the purification. Either the sample was too dilute and therefore could not be 
visualised, or it was too concentrated and aggregated. For optimal results (although not 
ideal) Dr Smith used the nickel column fractions for both negative stain and cyro 
transmission electron microscopy (EM). Figure 30A shows an example of the relatively 
heterogeneous population of particles present. The diameters of 100 randomly selected 
particles from different images were measured by myself. The mean average diameter was 
12.8 nm and diameters ranged between 9 and 16 nm, these values are consistent with 
previous unpublished TatAyCy work. Data was plotted on a size distribution graph, 30B.  
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Figure 30. Electron micrograph and size distribution analysis of TatAyCy. 
A. Negative stain electron micrograph of SMA and affinity purified TatAyCy sample.
B. Using ImageJ, the diameter of 100 random particles were measured and plotted onto a
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5.2.4 Negative stain single particle analysis 
Negative stain EM images were collected and analysed by Sarah Smith at the University of 
Warwick. Dr Smith also undertook data processing using Electron Micrograph Analysis 
(EMAN) (Ludtke et al. 1999). Individual images can often be noisy and hard to interpret, so 
post classification, similar images with constant features are aligned (Figure 31A) and titled 
(Figure 31B) to create the average TatAyCy particle. The protein complex generated has a 
doughnut like shape with a hole in the center.  
A
118 
Figure 31. Single particle reconstruction of TatAyCy from negative stain EM. 
A. Using EMAN, particles (purified with SMA and affinity chromatography) were
collected and classified into similar orientations. An example grouping is displayed on
p124. B. Reconstructions from different orientations were grouped to show the TatAyCy
particle from different angles. The red square is the reconstruction from (A) above.
B 
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5.2.5 Cryo-EM images of TatAyCy 
Given the success of TEM using negative staining, the next step towards gaining a more 
detailed structure of TatAyCy involved utilising cryogenic electron microscopy. Initially 
Sarah Smith commenced the Cryo-EM technique at the University of Warwick, but even 
after optomisation, results were poor. Optomisation methods for the small protein complex 
included making the ice particles very thin and freezing at 4oC with >90% humidity. For 
better quality images, grid samples of TatAyCy were taken to the Krios center in Leicester 
by Dr Corrine Smith. The Titan Cryo-EM has 300 kV compared to 200 kV at the 
University of Warwick, the higher the voltage, the more energy the electrons have and the 
further they go into the sample to produce a higher resolution image. However, the quality 
of the data was still disappointing (Figure 32), the 2D classes only are on par with negative 
staining, but the data should be much darker. Moreover, there is a lot of heterogeneity in 
the data set and some background. The background could be imidazole  
A 
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5.2.6 Initial TatAyCy 3D model generation 
Using 5 classes from the heterogenous data set, Dr Smith created 3D reconstructions of 
TatAyCy. Particle occupancy highlighted a definite preferred particle orientation on the 
grid (top views), the sides of the protein are not visible. Figure 33A indicates angle 
coverage (more red is more coverage), blue dots should cover the sphere but there are blank 
sides. Figure 33B graph shows how many particles belong to each of the 5 classes, the 
plateauing line towards the end of the run demonstrates that the algorithm/projection-
matching is ÒhappyÓ with the particle placing for each 3D classification below. Class 2 was 
used as a reference in the final 3D model generation using 7,164 particles in Figure 31C. 
B Figure 32. Electron micrograph and 2D 
classifications of TatAyCy from 
Cryo-EM
A. Cryo Electron micrograph of of SMA
and affinity purified TatAyCy sample.
B. TatAyCy sample 2D classifications
from Cryo-EM which show a lot of
heterogeneity is present in the data set. 5
classes (highlighted in red) were taken
further for initial 3D model generation.
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Figure 33.Cryo-EM angle coverage, particle occupancy and 3D classification. 
A. Angle coverage indicates a lack of coverage at the sides of TatAyCy, blue dots should
cover the sphere and red cylinders indicate best coverage, a preferred particle orientation is
present. B. Class percentage particle occupancy for the 5 particle classes chosen and their
corresponding 3D reconstructions. C. Class 2 was used as a reference in the final 3D model





5.2.7 Evidence other Tat subunits can be purified by SMA 
The optimisation of TatAyCy for cryo-EM analysis was a time consuming process, so we 
sought to only attempt the structural characterization of this complex during this study. 
Initially however other Tat proteins were cloned, expressed and purified using SMA for 
future analysis. Little is known about TatE (Section 1.3.2.2) but it shares 57% similarity to 
TatA, so this small protein (7 kDa) is interesting. Figure 32 shows TatE can also be purified 
by using SMA, affinity chromatography and size exclusion chromatography. In fact, about 
double the protein concentration of TatE was purified after SEC (Figure 34) which could 
result in better (less dilute) microscopy data in the future.  







Figure 34. Chromatogram and purification of SMAlp-purified TatE by SEC. 
After SMA and affinity chromatography, TatE sample was loaded onto a Size Exclusion 
Column. Peak fractions, 17- 19 and 34-36 were loaded onto a SDS-gel for verification. 
Fractions 34-37 on the coomassie above were identified as TatE by western blot to the 





Most membrane protein complexes and all Tat complexes so far have been stabilised and 
purified using detergents. Previously, particular focus has fallen on the bigger Gram- 
negative TatABC complex (Gohlke et al. 2005; Ramasamy et al. 2013) so little is known 
about the structure of or function of the minimal Gram- positive TatAC complexes. The 
detergents DDM and digitonin have thus far been used to study the complex size of 
TatAyCy, and the non-ionic detergents form large micelles of 70 kDa. Not only does the 
micelle contribute to complex size heterogeneity and ambiguity, but the solubilisation also 
strips away any native phospholipid bilayer that might be otherwise supporting the protein 
in vivo. 
In this study, we utilised a relatively new tool for membrane protein purification, styrene 
maleic acid (SMA) (Lee et al. 2016). The detergent free method exploits the hydrophilic 
and hydrophobic properties of SMAÕs copolymers to form a discoidal particle, which 
isolates proteins with their lipid bilayer to form SMA-lipid particles (SMALPs). The 
discoidal shape is size limited to about 15 nm in diameter, therefore the smaller Tat 
complexes, Gram- positive (~200 kDa) (Barnett et al. 2009) are more suited to this 
experiment. SMALP formation is not selective, but a 10X his tag on the N-terminal of each 
protein protrudes from the particle for ease of affinity chromatography.  
Recent advances in Cryo-EM technology mean the visualisation of small protein complexes 
in high resolution (<500 kDa) is now more attainable (Rapisarda et al. 2018). Therefore we 
sought to combine the two methods to further characterise TatAyCy. The ideal 
concentration of TatAyCy complex was difficult to achieve for Cryo-EM. To purify the 
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sample further, which is clearly required as the heterogeneity observed in Figure 30 is not 
ideal, size exclusion chromatography is necessary. The experiment was continued using 
only affinity chromatography purified samples. In hindsight, perhaps protein dialysis would 
have been useful to remove the imidazole for less background noise.  
Nonetheless, the preliminary data for SMALP-purified Tat is encouraging and is effective 
for both Tat complexes (TatAyCy) and individual subunits (TatE). The data presented in 
this study has reinforced the differences and similarities between Gram-positive and Gram-
negative Tat systems. TatAyCy is much smaller than TatABC but both translocases have 
inherent heterogeneity, which was observed before in Sarah SmithÕs thesis. Structural 
insight could help discover TatÕs export mechansim. Does TatAy form the translocase pore 
(Gohlke et al. 2005), weaken the phospholipid bilayer (Hou et al. 2018) or have another 
role? Like TatAd, the hole or pore seen in Figure 31 is simply too small to export the big 
proteins it can export (Beck et al. 2013). For example, one native substrate for TatAyCy, 
YwbN is 45 kDa but it can also export the recombinant protein GFP, which is 27 kDa. 
 
Further optimisations are required to better understand the structure of TatAyCy. The next 
step would be to quantify the complexÕs composition, how many subunits are within 
translocase? Other than the low resolution data presented from cryo-EM, another popular 
problem arose, preferred particle preference (Figure 33) so the sides of TatAyCy were not 
visualised. Perhaps carbon coating the grid could increase the number of views during 
Cryo-EM and method paperÕs exist for just this problem (Zi Tan et al. 2017). ItÕs also 
beneficial to understand that SMAlping is not the only non detergent protein purification 
method available, given more time, other tools such as nanodiscs and amphipols could be 
investigated too (Bayburt & Sligar 2010). 
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6.0 Final discussion  
 
The transport of protein across a membrane is an essential cellular function of almost all 
organisms. Nearly 30 years go, the Twin Arginine Translocase pathway was discovered, 
since then homologs to the translocase have been identified in many archaea, bacteria, 
chloroplasts and mitochondria (Yen et al. 2002). Every protein within a cell partakes in 
specific roles; the Tat protein complex is unique in that it transports fully folded protein 
(often with cofactors) across the plasma membrane to their site of function.  
 
Most knowledge regarding the Tat translocase originates from the Gram- negative E. coli 
system, which has 3 essential proteins (Berks 2015). TatA, TatB and TatC have all been 
studied in terms of both their structure and mode of function (reviewed in Chapter 1). Two 
main transportation mechanisms have been theorised and supported with scientific 
evidence. Initially, the pore forming mechanism was favored whereby the substrate binding 
dock Tat(A)BC (370 kDa) recruited separate TatA and this TatA complex formed a pore 
whose heterogenous size (100- 500 kDa) was dependent on substrate size (Oates et al. 
2005).  This theory was reinforced by low resolution EM images of TatA which showed 
ring shaped structures of varying diameter (9 - 13 nm) with a pore wide enough to 
accommodate one of the largest Tat substrates, TorA (90 kDa) (Gohlke et al. 2005). 
However, in light of new evidence, including that from Gram- positive Tat (Beck et al. 
2013) a different hypothesis has prevailed (Hou et al. 2018), where upon substrate binding, 
TatA protomers cause membrane destabilization (Brser & Sanders 2003) which allows 




TatÕs unqiue mechanism is not its only distinction as the translocase also has a quality 
control system that ensures only correctly folded and assmbled proteins are translocated 
(Robinson et al. 2011). Several studies mostly using E. coli Tat have probed this ability 
from both the substrate and translocase points of view, but the specifics of this process still 
remain unclear. Nevertheless, this capability is very advantagous to the biotechnology 
industry as recombinant proteins can be screened prior to periplasmic export which 
alleviates downstream purification requirements.  
 
In collaboration with Medimmune (AstraZeneca), the aims of my project comprised of 
investgating the Gram- positive Tat translocase for biopharmaceutical exploitation, 
including its quality control feature. Given the results from this study (Chapter 3) I went on 
to explore one specific biotherapeutic, an scFv, in different orientations and conditions in 
conjunction with TatExpress and TatAdCd (Chapter 4). Clearly, similarities and differences 
existed between the Gram-negative and Gram-positive translocases and so my final 
research tested a new membrane protein purification technique (SMA) with state of the art 
Cryo-EM technology to structually characterise TatAyCy (Chapter 5).  
 
The Bacillus subtilis TatAdCd system exhibits an extreme level of substrate specificity  
B. subtilis Tat differs from E. coli by lacking TatB; a minimal TatAC system transports 
proteins across the plasma membrane. One such TatAC system, TatAdCd with only one 
native substrate, PhoD (Pop et al. 2002) was shown previously in an E. coli tat null 
background to export native TorA and TorA-GFP (Albiniak et al. 2013). Here, I examined 
its ability to export a range of biotherapeutics including hGH, IFN, VH domain and 2 
different scFvs all with a TorA signal peptide. To our surprise, TatAdCd did not export the 
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majority of the proteins in this study including other native E. coli substrates but the 
minimal translocase did export both scFvs tested.  
 
We therefore took this opportunity to examine the proof reading ability of a Gram-positive 
Tat translocase using scFv variants. To get a clearer view of what Tat ÔsensedÕ as a mis-
folded protein to reject, scFv variants were designed with additional salt bridges, altered 
charge or further hydrophobicity, without changing the structural state of the substrate. The 
E. coli TatABC tolerated and exported all variants to the periplasm with the aid of 
CyDisCo (Jones et al. 2016). In contrast, TatAdCd completely rejects many of the variants 
and preliminary suggests it cannot tolerate substrates above a certain hydrophobic 
threshold. This combined data shows the two systems have different substrate specificities 
and selectivity.  
 
Auto Induction Media (AIM) aids Tat mediated scFv export to the periplasm 
Given the success of scFv export via both TatABC and TatAdCd, the next study (Chapter 
4) sought to scale up scFv production by Tat. The CEA scFv was different from the two in 
the previous study and was provided by MedImmune (Osbourn et al. 1996) in 8 different 
orientations to trial for expression and export with a Tat specific TorA signal peptide. In all 
media (LB, TB, SM6 and AIM) tested, only the VH-VL orientation expressed and the 
disulphide stabilised variant either made no difference or decreased protein expression.  
 
The two scFvs in Chapter 3 had different CyDisCo requirements; scFvO did not require 
CyDisCo for export, but scFvM was CyDisCo dependent. No-CyDisCo, CyDisCo on an 
alterative plasmid and polycistronic CyDisCo expression were all tested with CEA scFv, 
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and the results showed CyDisCo expression increased expression and hence, export 
quantities.  
 
The biggest surprise of this investigation was that only when grown in AIM did CEA scFv 
export to the periplasm. In the literature, both protein solubility and expression levels of 
proteins have risen using AIM, but I cannot find any literature demonstrating the ability of 
AIM to promote export of a protein that was otherwise not exporting to the periplasm. One 
can only assume the combination of customised induction (when each cell reached the right 
metabolic state) and TatÕs unique mechanism are very compatible for export. 
 
Detergent free, SMAlp purification and visualisation of TatAyCy  
In pursuit of exploiting Tat for Biotechnology, we confirmed Gram-negative and Gram-
positive Tat systems are different. Therefore, to structurally characterise another B. subtilis 
Tat translocase, TatAyCy, we used a novel method of membrane protein purification, 
styrene maleic acid lipid particles in conjunction with the latest Cryo-EM technologies. The 
purification of TatAyCy and TatE using SMA was very successful but a higher yield after 
SEC could have improved Cryo-EM data quality.  
 
The data obtained from negative stain and cryo-EM showed TatAyCy is a much smaller, 
homogenous complex than TatABC. Like TatAdCd, TatAyCy has a ÔporeÕ like structure, 
which is too small to transport the big proteins itÕs capable of exporting like TorA (Beck at 
al. 2013). This preliminary data therefore does not support the TatA pore forming 
mechanism but for more conclusive results (like how many subunits fit into a complex) 




6.1 Future perspectives 
Given the different substrate selectivities and specificities of TatAdCd and TatABC, it 
would be interesting to investigate alternative Tat systems. Would exploiting 
Agrobacterium, Rhizobia or Cyanobacterial Tat in E. coli produce a substrate selectivity 
pattern? How would the new Tat systems respond to recombinant protein production and 
export? Given that the work in this study has used a dual plasmid system (with TatAdCd on 
pBAD), I think the way forward would be cloning the different Tat systems onto the E. coli 
chromosome, as has been done with TatExpress cells. 
  
As regards to the scFv variants, the next experiment I would like to test is whether 
TatAdCd can export the scFvs with CyDisCo on the same plasmid. If so, this would further 
add to the catalogue of scFvs it can export. It goes without saying that finding out why 
TatAdCd preferentially exports scFvs over smaller and less complicated biotherapeutics 
would be interesting. Testing export of similar format biotherapeutics for T cell receptors, 
scTvÕs (Aggen et al. 2012) could provide some answers. Checking for diabody formation in 
the periplasm for CEA 003 construct using a blue native gel would also confirm whether 
Tat can export diabodies.  
 
Structural characterisation supports the process of fundamentally distinguishing the Gram- 
positive and Gram- negative Tat systems. This study has shown that non-detergent methods 
(SMA) can isolate the Tat system effectively. I believe this process, with optimisation, 
higher yields post SEC and during Cryo-EM could at least verify the number of subunits in 
TatAyCy complex. The golden ticket would be to trap a substrate within the protein 
complex or produce a functional assay to prove TatAyCy is active within the SMAlp. 
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This study has shown both Gram-negative and Gram- positive Tat have the potential to be 
used within the biotechnology industry. However, more research is required to understand 
how its quality control feature works (particularly in B. subtilis) and it would be interesting 
to understand how its export mechanism functioned. Recent advances in science, such as 
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